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Medical	imaging	has	enormous	potential for	early	disease	prediction,	but	is impeded by	the	difficulty	and	
expense	of	acquiring	datasets	prior	to	symptom	onset.	UK	Biobank aims	to	address	this	problem	directly
by	 acquiring	 high	 quality,	 consistently	 acquired imaging	 data	 from	 100,000	 predominantly	 healthy	
participants,	with	health	outcomes	tracked	over	coming	decades.	The	brain	imaging	includes	structural,	
diffusion	and	 functional	modalities. Along	with	body	and	cardiac	 imaging,	genetics,	 lifestyle	measures,	
biological	phenotyping	and	health	records,	this	is	expected	to enable	discovery	of	imaging	markers	of	a	
broad	 range	 of	 diseases	 at	 their	 earliest	 stages,	 as	 well	 as	 provide	 unique	 insight	 into	 disease	
mechanisms.	We	describe	UK	Biobank	brain	 imaging,	and	present	results	derived	 from	 the	 first	 5,000	
participants’	data	release.	Although	that covers just	5%	of	 the	ultimate	 cohort,	 it	 already	 yields a	 rich	
range	of	associations	between	brain	imaging	and	other	measures	collected	by	UK	Biobank.	
The	primary	clinical	role	of	brain	imaging	to	date	has	been	in	diagnosis	and	monitoring of	disease	progression,	
rather	than	providing	predictive	markers	 for preventative	stratification	or	early	 therapeutic	 intervention. The	
predominant	 strategy	 for finding image-based	 markers	 of	 neurological	 and	 psychiatric	 disease has	 been	 to	
identify	patients	early	in	the	diagnostic	process	to	maximize	statistical	power	in	a	small	cohort	(tens	to	hundreds	
of	 subjects). A	 key	 factor	 motivating	 the	 use	 of	 small,	 clinically-defined	 cohorts is	 the	 expense,	 time	 and	
specialized	hardware	associated	with	imaging.	This	approach	has	been	effective	in	providing	markers	of	disease	
progression,	but	 identifying imaging	markers	of	early	disease	requires	measurements	at	 the	pre-symptomatic	
stage.	Image-based	measures	of	brain	structure	and	function	may	evolve	in	a	complex	way	throughout	aging	and	
progression	 of	 neuropathology.	 Therefore,	 markers	 with	 utility	 in	 monitoring	 disease	 progression	post-
diagnostically	 may	 not	 manifest	 pre-symptomatically,	 and	 conversely	 the	 most	 sensitive	 early	 predictors	 of	
disease	may	have	plateaued	by	the	time existing diagnoses	become	accurate.
Nevertheless, when	known	risk	 factors	have	enabled	 risk-stratified	 cohorts, imaging	 has	 been	 able	 to	 predict	
disease before	 symptom	 presentation.	 For	 example,	 magnetic	 resonance	 imaging	 (MRI)	 has	 demonstrated	
altered	 brain	 activity	 associated	 with the APOE	 genotype	 decades	 in	 advance	 of	 symptoms	 associated	 with	
Alzheimer’s	disease
1
,	and conversion	from	mild	cognitive	impairment	to	Alzheimer’s	has	been predicted
2
.	These	
studies suggest	 that the	 primary	 obstacle	 to	 identifying	 early	 imaging	 markers	 is	 in	 obtaining	 data	 in	pre-
symptomatic	cohorts	drawn	from	the	general	population.
Alternatively,	pre-symptomatic	cohorts	can	be	assembled	using	a	prospective	approach,	in	which	a	large	number
of	 healthy	 participants are	 intensively	 phenotyped	 (including	 imaging)	 and	 subsequently	monitored	 for	long-
2term	health	outcomes.	While	this	approach	is	expensive,	 it	 is	also	efficient	by	capturing	early	biomarkers	and	
risk	 factors	 for	 a	 broad	 range	 of	 diseases.	 It	 further	 becomes	 possible	 to	 discover	 unexpected	 interactions	
between	risk	factors	(such	as	 lifestyle	and	genetics). To	date,	 the	 largest	brain	 imaging	studies	have	gathered	
data	on	a	few	thousand	subjects.	While	 this	approach	has	 identified	associations	between	imaging	and	highly	
prevalent	 diseases,	 existing cohorts	 are	 still	 too	 small	 to	 produce	 sufficient	 incidence	 of	 many	 diseases	 if
participants	are	recruited	without	identifying	risk	factors.
UK	Biobank	is	a	prospective	epidemiological	resource	gathering	extensive	questionnaires,	physical	and	cognitive	
measures	 and	 biological	 samples	 (including	 genotyping),	 in	 a	 cohort	 of	 500,000	 participants
3
.	 Participants	
consent	to	access	to	their	full	health	records	from	the	UK	National	Health	Service,	enabling	researchers	to	relate	
phenotypic	measures	 to	 long-term	 health	 outcomes.	 This	 is	 particularly	 powerful	 due	 to	 the	 combination	 of	
number	of	subjects	and	breadth	of	linked	data.	Participants	were	40-69	years	of	age	at	baseline	recruitment; this	
aims	 to	 balance	 the	 goals	 of	 characterizing	 subjects	 prior	 to	 disease	 onset	 against	 the	 delay before	 health	
outcomes	accumulate.	The	cohort	is	particularly	appropriate	for	study	of	age-associated	pathology.	All	data	from	
UK	Biobank	are	available	to	researchers	world-wide	upon	application,	with	no	preferential	access	for	scientists	
leading	the	study.	An	imaging	extension	to	the	existing	UK	Biobank	study	was	funded	in	2016	to scan	100,000	
subjects	from	 the	 existing	 cohort, aiming	 to	 complete	 by	2022.	 Imaging	 includes	MRI	 of	 the	 brain,	 heart	 and	
body, low-dose	x-ray	bone	and	joint	scans,	and	ultrasound	of	the	carotid	arteries.	Identification	of	disease	risk	
factors	should	increase	over	time	with	emerging	clinical	outcomes.	For	example,	within	the	imaged	cohort,	1800	
participants	are	expected	to	develop	Alzheimer’s	disease	by	2022,	rising	to	6000	by	2027	(diabetes:	8000	rising	
to	14,000;	stroke:	1800	to	4000;	Parkinson’s:	1200	to	2800)
4
.
We present	example	analytic	approaches and	studies that	will	be	enabled	by	UK	Biobank. Identification	of	novel	
imaging	biomarkers	 of	 disease	 risk	 could	 support	 diagnosis,	 development	 of	 therapeutics,	 and	 assessment	 of	
interventions.	The	multi-modal,	multi-organ	imaging	enables	study	of interactions	between	organ	systems,	for	
example,	between	cardiovascular	health	and	dementia.	The	breadth	of	imaging	makes	this	dataset	valuable	for	
multi-systemic	syndromes	such	as	frailty,	accelerated	aging	characterized	by	general	 loss	of	reserves	and	poor	
tolerance	to	stressors,	which	indicates	increased	risk	for	a	range	of	conditions	including	dementia
5
.	This	kind	of	
resource	can	also evince hypotheses	regarding	causal	mechanisms	of	disease	that could be	tested	in	follow-up
interventional	studies.	Examples	include modifiable	risk	factors,	such	as	the	association	of	obesity	with	later	life	
cognitive	dysfunction
6
,	and	the	ability	to	study	complex	interactions	of	risk	factors	with	lifestyle,	environment	
and	genetics.	Finally,	UK	Biobank	will	enable	validation and	extension of	associations	identified	by	smaller-scale
studies,	including testing	of	hypotheses	that	combine	results	from	multiple	previous	studies.
RESULTS
Design	rationale	and	initial	imaging	phase
The	imaging	study	was	designed	to	achieve	the	target	of	100,000	subjects,	each	scanned	once,	over	5-6	years	at
three	 dedicated,	 identical centers	 operating	 7	 days/week,	 each scanning	 18	 subjects/day
7
.	 This	 places	 tight	
timing	 constraints,	 corresponding	 to	 one	 subject	 imaged	 every	 36	 minutes	 (see	 Online	 Methods).	 The	 first	
imaging	center was	built	to	establish	feasibility	and scanned	10,000	subjects	over	a	two-year	ramp-up	period.
Two	 further	 identical	 centers	 are	 being	 commissioned,	 with	 the	 three centers	 strategically	 positioned	 at
population	hubs: Manchester,	Reading	and	Newcastle.
The	 goal	 of	 capturing	 imaging	 phenotypes	 relevant	 to	 the	widest	 possible	 range	 of	 diseases	 and	 hypotheses	
meant	that	the	protocol	must	deliver	data	with	 the	broadest	predictive	power	 for	neuropathology	and	mental	
health.	We	 therefore	 included	modalities	that	drive	estimates	of	anatomical	and	neuropathological	 structure	(
“structural	MRI”),	brain	activity	 (“functional	MRI”,	 or	 fMRI),	 and	 local	 tissue	microstructure	 (“diffusion	MRI”,	
dMRI).	 The	 resulting	 imaging	 protocol	 (Supplementary Table	 1)	 included: three	 structural	 modalities,	T1-
weighted,	T2-weighted	and	susceptibility-weighted	MRI	(referred	to	here	as	T1,	T2	and	swMRI); dMRI;	and	both	
task	 and	 resting-state	 functional	 MRI	 (tfMRI	 and	 rfMRI).	 Recent	 advances in	 MRI	 acquisition	 technology
8
enabled	high	spatial	resolution	dMRI	and	fMRI	with	high	angular	and	temporal	resolution,	respectively,	despite	
strict	 time	 constraints.	 For	 example,	 the	protocol	 acquires	 dMRI	 data	with	 100	 diffusion-encoding	 directions	
over	two	shells	in	just	7	minutes,	enabling	advanced	model	fitting	of	microstructural	parameters	that	would	not	
have	been	possible	under	these	time	constraints	with	previous	generation	technology.	Following	optimization	of	
acquisition	protocols,	streamlining	of	participant	preparation	and	minimization	of	scanner	dead	time	(see	Online	
Methods), UK	Biobank was	able	to	incorporate	six	neuroimaging	modalities	in	just	36	minutes.
Unlike	most	of	the	measurements	included	in	the	original	UK	Biobank	resource	(e.g.,	alcohol	consumption	and	
cognitive	test	scores),	raw	imaging	data	is	not	a	directly	useful	source	of	 information.	In	addition	to	requiring
image	processing	 to	 remove	 artefacts	 and	 align	 images	 across	modalities	and	 individuals,	most	 useful	 image	
3phenotypes	are	derived	through	complex	calculations	combining	many	voxels	and/or	images.	A	fully	automated	
processing	 pipeline was	 developed,	 producing	 both	 processed	 images	 as	 well	 as	 image-derived	 phenotypes	
(IDPs)	–	currently	2501	distinct	individual	measures	of	brain	structure	and	function.	Example	IDPs	include:	the	
volume	of	specific	brain	structures;	the	strength	of	connectivity	between	pairs	of	brain	 regions;	 the	estimated	
dispersion	 of	 fibers	 in	 a	 given	 white	 matter	 tract. IDPs	 are intended	 to	 be	 useful	 for	 non-imaging	 experts;	
however,	understanding	of	the	confounds	and	pitfalls	of	imaging	is	required	to	draw	appropriate	conclusions.
We	present	results	from	the	first	data	release	(biobank.ctsu.ox.ac.uk/crystal/label.cgi?id=100),	which	 includes	
outputs	from	the	processing	pipeline	for 5285	subjects	scanned	in	2014-2015.	As	determined	by	the	processing	
pipeline,	98%	of	participants’	datasets	resulted	in	a	usable	T1,	which	is	crucial	for	deriving	usable	information	
from	the	other	modalities.	Of	these,	data	for	the	other	brain	imaging	modalities	were	suitable	for	processing	in
the	 following	 percentages	 of	 subjects:	 T2=97%,	 swMRI=93%, dMRI=95%, tfMRI=92%,	 	 rfMRI=95%.	 	 All
modalities	were acquired	and	usable in	89% of	subjects.	Results	from this	data	release	are	illustrated	in	Figs	1-4,
including	a	multimodal	atlas	(separate	population-average	images	for	each	of	the	modalities,	all	aligned	to	each	
other),	 available	 for	 download	 and	 online	 browsing	 (www.fmrib.ox.ac.uk/ukbiobank).	 Below,	we	 present	 the	
following	analyses:	voxel-by-voxel	analyses	of	age	effects;	pair-wise	correlations	of	brain	IDPs	with	other	subject	
measures;	multivariate	analysis	identifying	dominant	population	patterns	linking	brain	IDPs	to	other	measured	
parameters;	and	an	exemplar	hypothesis-led	study	of	aging,	body	mass	index	and	smoking.
Imaging	data,	atlases	and	imaging-derived	phenotypes
The	 three	 structural modalities	 (Fig	 1)	 provide	 information	 about	 different	 aspects	 of	 the	 brain’s	 tissues,	
structures	 and	 neuropathologies.	 Data	 quality	 at	 the	 single-subject	 level	 is	 illustrated	 in	Fig	 1a,b.	 The	group-
averaged	images	produced	for	each	modality	are	included	in	the	initial	data	release	as	high-quality	atlases	(Fig	
1c-f),	depicting	strong	tissue	contrast	and	excellent	fidelity	of	alignment	across	subjects.	The	T1	modality	(Fig	
1a,c)	 is	the	most	informative	about	the	basic	structure	of	the	brain,	 including	the	depiction	of	the	main	tissue	
types	(gray	and	white	matter)	and	gross	structure	of	the	brain	(main	anatomical	landmarks).	From	the	T1	data,	
we	derived	25	volumetric	IDPs:	total	tissue	volumes	(gray,	white	and	ventricular	cerebro-spinal	 fluid),	and	the	
volumes	of	subcortical	gray	matter	structures	such	as	thalamus,	caudate,	putamen,	pallidum,	hippocampus	and	
amygdala.	The	T1	data	and	T1-derived	 IDPs	provide	sensitive	markers	of	atrophy	 (tissue	 loss),	which	 can	be	
both	global	(e.g.,	thinning	of	the	cortex	in	aging)
9
	and	local	(e.g.,	reduction	of	hippocampal	volume	in	Alzheimer’s	
disease)
10
.	The	T2	data	(Fig	1b,d)	is	a	FLAIR	(fluid-attenuated	inversion	recovery)	acquisition	that	also	depicts	
basic	 anatomy,	 but	 is	 valuable	 primarily	 for	 detection	 of	 focal	 “hyperintensities”	 (i.e.,	 high-signal	 regions)	 in	
white	matter.	T2	hyperintensities	represent	white	matter	lesions	that	have	been	associated	with	a	broad	range	
of	 neuropathological	 conditions
11
	 (e.g.,	 small	 vessel	 ischaemic	 disease),	 as	 well	 as	 occurring	 with	 increasing	
incidence	 in	 aging	 populations	without	 (or	 potentially	 before)	manifestation	 of	 neurological	 symptoms.	 IDPs	
relating	to	the	volume	of	these	white	matter	lesions	will	be	included	in	future	data	releases.	swMRI	is	a	flexible	
modality	that	can	be	processed	in	multiple	ways,	each	sensitive	 to	different	clinically-relevant	properties.	The	
first	data	release	 includes	T2*	signal	decay	 times	and	enhancement	of	venous	vasculature	using	susceptibility-
weighted	image	(SWI)	filtering
12
	(Fig	1e,f). swMRI	IDPs	in	the	current	data	release	are	the	median	T2*	in	each	of	
14	major	subcortical	gray	matter	 structures,	 for	example	reflecting	 increased	 iron	deposition	 associated	with	
neurodegeneration
13
.
Diffusion	MRI	 (Fig	2)	 reflects	 the	 random	diffusion	 of	water	molecules,	which	 is	 affected	by	 the	microscopic	
structure	 of	 tissue
14
,	 enabling	 us	 to	 infer	 the	 local	 density	 of	 cellular	 compartments	 in	 tissue	 (e.g.	 neurites).	
Additionally,	 axon	 bundles	 in	 white	 matter	 create	 an	 orientation	 dependence	 of	 water	 movement	 due	 to	
hindrance	of	diffusion	perpendicular	to	the	long	axis	of	white	matter	tracts,	an	effect	that	can	be	tracked	from	
voxel	 to	 voxel	 (“tractography”)	 to	 derive	 long-range	white	matter	 pathways.	 Three	 complementary	 diffusion	
models	 were	 fit	 to	 the	 signal	 in	 each	 voxel:	 (i)	 the	 diffusion	 tensor	 model
15
,	 describing	 the	 signal	
phenomenologically	as	resulting	from	a	3D	ellipsoid	profile	of	water	displacement;	 (ii)	 the	neurite	orientation
dispersion	 and	 density	 imaging	 (NODDI)	 model
16
,	 estimating	 microstructural	 properties	 (e.g.,	 neurites	 vs.	
extracellular	space);	and	(iii)	the	ball	&	sticks	model
17
,	estimating	the	orientation	of multiple	fiber	populations	
within	a	voxel for	tractography.	675	IDPs	were	extracted,	by	averaging	parameters	estimated	by	 the	 first	 two	
models	 over	 75	 different	 white-matter	 tract	 regions	 based	 both	 on	 subject-specific	 tractography
18
	 and	 from	
population-average	white	matter	masks
19
.
fMRI	reflects	neural	activity	indirectly,	based	on	dynamic	changes	in	blood	oxygenation	and	flow	resulting	from	
changes	 in	 neural	 metabolic	 demand
20
.	 The	 task	 deployed	 in	 tfMRI	 (Fig	 3)	 involves	 matching	 shapes	 and	
emotionally	negative	faces
21
	and	was	chosen	to	engage	a	 range	of	neural	 systems,	 from	 low-level	 sensory	and	
motor	 to	 perceptual	 (e.g.,	 fusiform)	 and	 emotional	 (e.g.,	 amygdala)	 areas.	 The	 16	 tfMRI	 IDPs	 quantitate	 the	
strength	of	brain	activity	changes	for	specific	aspects	of	the	task,	 in	regions	defined	using	the	group-averaged	
activation	maps	shown,	 in	three	task	conditions.	Resting-state	fMRI	(Fig	4)	 identifies	connected	brain	 regions	
4based	on	common	 fluctuations	 in	activity	over	 time	 in	 the	absence	of	 an	 explicit	 task
22
.	 Sets	 of	 voxels	 that	co-
fluctuate	most	strongly	correspond	to	brain	regions,	referred	to	as	network	“nodes”;	different	nodes	may	have	
weaker	co-fluctuations	indicating	a	connection	between	them,	a	network	“edge”.	The	group	analysis	of	the	rfMRI
data	generated	two	atlases	of	these	functional	networks	-	a	“low-dimensional”	decomposition	of	the	brain	into	
21	functional	sub-divisions	and	a	higher-dimensional	parcellation	into	55	sub-divisions.	IDPs	represent	a)	edge	
connectivity	strengths	and	b)	node	fluctuation	amplitudes	(Fig	4).
Voxel-wise	associations	with	aging
IDPs	reduce	raw	data	into	a	compact	set	of	biologically-meaningful	measures,	with	current	measures condensing
~2GB	 raw	data	 per	 subject	 into	 2501	 IDPs,	 but such summary	measures	 can	 lose	 valuable	 information.	 For	
example,	once	aligned to	common	coordinate	systems,	images	can	be	analysed	for	cross-subject	variation	at	the	
voxel	level	to	provide	a	more	spatially-detailed	exploration	than	can	be	achieved	via	IDPs.	However,	this	requires	
greater	imaging	expertise	and	computational	resources,	as	well	as	often	leading	to	lower	statistical	power	(due	
to	the	greatly	increased	number	of	multiple	comparisons	and	the	higher	noise	in voxel-wise	measures	compared	
with	regional	averages). Below,	we	present example	voxel-wise	associations	with	aging.	
Fig	5	presents	voxel-wise	correlations	of	age	with	several	parameters	modeled	from	the	dMRI	data	(along	the	
centers	of	the	main	white	matter	tracts),	as	well	as	normalized	T2	FLAIR	intensity	in	the	white	matter.	Fractional
anisotropy	(FA),	a	sensitive	but	non-specific	marker	of	white	matter	integrity,	predominantly	demonstrates	the	
established	reduction	of	FA	with	aging	(Fig	5a,g). However,	some	voxels	exhibit	the	opposite, of	FA	increasing
with	aging,	which	may	reflect degradation	of	secondary	fibers	or	reduced	fiber	dispersion
23
; notably, none	of	the	
FA-based	 IDPs	 exhibit	 this	 significant	 positive	 correlation,	 demonstrating	 that	 averaging	 across	 tracts	 can	
sacrifice	 richness	 of	 information.	 The tensor	 mode
24
	 (Fig	 5b),	 which	 primarily	 describes	 whether	 a	 voxel	
contains	one	vs.	multiple	tracts, was	even	more	sensitive	with	highly	significant	positive	correlations	in certain	
association	fiber	areas	and	posterior	corpus	callosum	(arrows),	likely	the	same	effect	seen	as	FA	increases
23
.	We	
further	observed	an	increase	in	free	water	with	aging	(Fig	5d);	the	strongest	increase,	in	the	fornix	(arrow),	 is	
likely	due	to	an	increase	of	the	fraction	of	CSF	within	voxels	spanning	this	thin	tract	as	it	atrophies. Finally,	we	
calculated	voxel-wise	cross-subject	correlation	of	age	with	T2 images.	This	analysis	 identified	peri-ventricular	
areas,	which	are	most	susceptible	to	white	matter	hyperintensities known	to	be	associated	with	aging (Fig	5e).
A	 further	 example	 voxelwise	 analysis	 is	 shown	 in	 Supplementary	 Fig	 1,	 where	 the	 rfMRI	 data	was	 used	 to	
investigate	aging	effects	in	 the	default-mode	resting-state	 network
25
.	 This	also	 provides	 a	demonstration	 that	
group	 analyses	 do	not	 degrade	with	 increasingly-large	 subject	 numbers	 (e.g.,	 due	 to	 alignment	 issues),	 using
group	sizes	from	15	to	5000.	With	increasing	subject	numbers,	background	noise	is	suppressed	without	increase	
in	 spatial	 blurring,	 and	 localized	 estimates	 of	 age-dependence	 stabilize,	 with	 statistical	 significance	 rising	
indefinitely.
Pairwise	associations	between	brain	IDPs	and	other	measures	
We	conducted	simple	univariate association	analyses to	illustrate	the	richness	of	relationships	between	IDPs	and	
other	available	variables,	as	well	as	the	statistical	power	afforded	by	~5000	subjects.	We individually correlated
all	2501	brain	IDPs	with	1100	other Biobank variables,	where	the	latter	were	broadly	grouped	into	11	categories
(Figs 1-4,6,	Supplementary	Fig	2). Even	after	 false	discovery	rate	 (FDR)	multiple	 comparison	correction	for	
these	 2.8	 million	 correlations,	 57	 out	 of	 the	 66	 combinations	 of	 brain	 modalities	 and	 non-brain-imaging	
categories show	significant	associations.	Some	variable	categories exhibited	large	numbers	of	associations	with	
IDPs	(e.g., height	and	weight),	whereas	others	(e.g. cognitive	measures	and	alcohol/tobacco	 intake)	had	more	
focused associations.
The	above	associations	were	estimated	after	adjusting	all	variables	for	age,	sex,	age-sex	interaction,	head	motion	
and	head	size	 (“de-confounding”). Some	 factors can	 be	 unambiguously	 considered	 a	 confound	 to	 be	 removed
(e.g.,	head	motion, which	can	corrupt	IDPs	but	also	correlates	with	disease/aging
26
).	For	other	factors	(e.g., age),
the	 appropriateness	 of	 de-confounding	 depends	 on	 the	 question	 being	 asked	 and	 needs	 to	 be	 taken	 into	
consideration	 when	 interpreting	 associations	 (see	 Discussion). The	 relationship	 between	 the	 correlations	
estimated	 with	 vs. without	 de-confounding	 (Fig	 6d) demonstrates	 that	 in	 almost	 all	 cases	 the	 strength	 of	
association	was	 reduced	 by	 de-confounding, in	 some	 cases being	 almost	 entirely	 removed	 (horizontal	 cloud	
around	y=0).
We	 considered	 associations	 between	 cognitive	 tests	 and	 brain	 IDPs, including potential	 age	 interactions,	 in	
greater	detail.	Sex,	head	motion,	and	head	size	were	regressed	out	of	all	data	before	computing	correlations	(see	
Online	Methods). Figure	6b	shows Bonferroni-significant	(Puncorrected<1.8x10
-8
)	associations	with	brain	IDPs,	both
with	and	without adjusting	for	age. The	task-fMRI	vs.	Fluid	Intelligence	associations are	unchanged	by	adjusting	
for	 age,	whereas	 all	 other	 cognition-IDP	 correlations	 are	 approximately	 doubled, being significantly stronger
5(Pcorrected<0.005) without	age	adjustment.
In	the	Symbol	Digit	Substitution	test,	participants	replace	symbols	with	numbers	using	a	substitution	key. Strong	
IDP	associations	were found	with	 two	 scores:	Number	 of	 symbol	 digit	matches	made	 correctly and Number	 of	
symbol	digit	matches	attempted in	the	time	allowed (because	subjects	rarely	make	mistakes,	these	two	scores	are	
highly	correlated, r=0.97).	These	scores	correlated	negatively	with	measures	of	water	diffusivity	in	the corona	
radiata	and	superior	thalamic	radiation,	and	with	FA	in	the	posterior	fornix	(consistent	with	literature
27
,	which	
as	discussed	above	may	reflect	variations	 in	 tract	 thickness
28
).	 Finally,	 there	was	 significant	 association	with	
thalamus	 volume	 (right	 thalamic	 volume	 significant,	 left	 thalamic	 volume	 close	 to	 significance	 with	 r=0.10),	
consistent	with	 literature
29
.	These	negative	associations likely	 reflect	 lower	cognitive	 performance	with	 aging	
and	pathology	(increased	diffusivity	and	atrophy).
In	the	Reaction	Time	test,	subjects	confirm	whether	two	abstract	 symbols	match	as	quickly	as possible.	Mean	
time	to	correctly	identify	matches	was	found	to	correlate	inversely	with	left	putamen	volume	(right	putamen	had	
similar	 correlation,	 r=-0.06,	 but	 was	 below	 significance).	 These	 negative	 associations	 are	 consistent	 with
literature
30
	 and	 indicate	 increased	 volume	 correlating	 positively	 with	 cognitive	 speed	 (and	 negatively	 with	
reaction	time).
The	Fluid	 Intelligence	score	reports	how	many	numerical,	 logic	and	syntactic	questions	subjects	were	 able	 to
answer	 in	 two	minutes. This	was	 negatively	 correlated	with	 strength	 of	 gray	matter	 activation	 in	 the	 simple	
shapes	matching	task	in	tfMRI,	with	no	age	interaction. The	shapes	matching	task	incurs	low	cognitive	demand,	
and	 it	 is	 plausible	 that	 higher	 intelligence	 requires	 less	 neural activity	 for	 this	 task,	 a	 mechanism	 that	 has	
previously	been	ascribed	to	“minimization	of	cognitive	workload”
31
.	
All	 cognitive	scores	 reported	 above	 involve	 processing	 speed	 as	 a	 significant	 factor,	 consistent	with	 previous	
studies
27
.	However,	the	observation	that	different	test	scores	do	not	all	correlate	identically	with	each	other	or	
with	 the	 same	 brain	 IDPs	 suggests	 that	 there	 is	 not	 a	 single	 (speed-related)	 cognitive	 factor	 at	 play.	 The	
increases	 in association	strengths	when	not	controlling	 for	age	suggest	 that	 age-related	 cognitive	 decline	 is	 a	
major	 source	 of	 cross-subject	 variability	 for	 these	 IDP-cognition	 associations
28
.	 Plotting all IDP-cognitive	
associations	 (Fig	6c)	 demonstrated	 that a	 large	 number	 of	 non-age-adjusted	 associations	 (gray	 circles)	were	
stronger	 than	 the	 results	 after	 age	 adjustment	 (colored	 circles);	 below,	we	 show	 how	 interpretation of	 such	
results	can	be	aided	 further	 through	multivariate	analyses.	These	age interactions	provide	an	early	 indication	
that	UK	Biobank should	provide cognitive	biomarkers	of	clinical	significance	as	health outcomes	accumulate.
Multivariate	associations:	modes	of	population	variation
We	conducted	multivariate	analyses	using	 canonical	 correlation	 analysis	 (CCA
32
)	 combined	with	 independent	
component	analysis	(ICA
33
) (see	Figs	7-8, Supplementary	Figs	3-7 and	Online	Methods).	This	analysis	identifies	
“modes”	 of	 population	 covariation	 linking	 IDPs	 to	 non-imaging	 measures.	 Each	 mode	 consists	 of	 one linear
combination	of	IDPs	and	a	separate	combination	of	non-imaging	measures	that	have	a	highly	similar	variation	
across	subjects. The	strength	of	involvement	of	a	variable	in	a	given	mode	is	dictated	by	the	variable	weight	(Fig	
7).	Multiple	population	modes	may	be	identified,	provided	they	describe	different	 (independent)	cross-subject	
variation,	meaning	that	the	implied	association	between	a	given	pair	of	variables	can	vary	from	mode	to	mode.	
From	the	current	UK	Biobank	release,	we	identified nine	modes	that	were	highly	significant	(Pcorrected<0.002,	no	
further	modes	significant	at	Pcorrected<0.05).	Similar	methodology	using	Human	Connectome	Project	 (HCP)	data
previously identified	 a	 single	 statistically-significant	 mode	 of	 population	 covariation	 in	 461	 young	 healthy	
adults
8,	34
. Our	ability	to	identify	more	modes than	in	the	HCP	dataset	could	be	due	to	the	tenfold	increase	in	the	
number	of	 subjects,	 the	 larger range	 of	 imaging	modalities	 and	 non-imaging	 variables,	 and	 the	 older	 subject	
ages.	
While	 these	 modes	 are	 not	 guaranteed	 to	 reflect	 biological	 processes,	 in	 practice	 ICA	 often	 produces	 such	
interpretability
35
.	 Of	 the	nine	modes,	 some	 reflected	 dominant	 physical	 factors	 (e.g., body	size	 or	 heart	 rate),
while	others	linked	rich	subsets	of	non-imaging	measures	to	IDPs. Modes	7-9	are	displayed	in	Fig	7,	with	modes	
7	and	9	discussed	 in	detail	below,	 continuing	our	 focus	on	 the	relationship	between	 IDPs	and	cognitive	 tests.
Modes	1-6	are	overviewed	 in	Supplementary	Figs	3-7. The	relationship	of	 these	multivariate	associations	 to	
potential	confounds	and	variables	of	interest,	including	some	clinical	outcomes, is	explored	in	Supplementary
Fig	8.	Modes	1,2,4,5,7,8	were	strongly	associated	with	aging,	whereas	3,6,9	were	not.	
Mode	7	primarily	links	bone	density	measures	and	cognitive	scores	to	brain	structure	and	dMRI	measures.	There	
is	extensive	 literature	 linking	volume	 and	diffusivity	measures	 to	 cognition,	 but	 a	 relationship	 between	 these	
measures	and	bone	density	has	not	to	our	knowledge	been	reported.	This	link	could	reflect	variations	in	physical	
properties	of	non-interest	 that	are	not	 fully	 accounted	 for	 by	 de-confounding.	However,	 correlations	 between	
low	bone	density	and	accelerated	cognitive	decline	have	been	reported
36
	 including	association	of	bone	density	
6with	Alzheimer’s	disease
37
.
Mode	 9	 exhibited	 the	 most	 complex	 population	 pattern	 (Fig	 7c).	 The	 most	 strongly-involved non-imaging	
measures were	intelligence,	education	levels	and	occupational	factors;	additionally,	 some	physical	and	dietary
measures are	involved,	that may	reflect	socio-economic	status	as	a	latent	factor	(e.g.,	cheese	intake	or	time	spent	
outdoors	in	winter).	Associated	brain	IDPs	include	task	fMRI	(with	a	negative	weight,	consistent	with	the	sign	of	
univariate	associations,	discussed	above),	followed	by	a	range	of	functional	and	structural	IDPs.	
There	 is	 some	overlap	 between	modes	 7	 and	 9	 in	 terms	 of	 cognitive	 tasks	 (e.g., symbol	 digit	matches),	 bone	
density	and	T1-based	brain	volumes.	However,	 the	 fact	 that	CCA-ICA	separated	modes	7	and	9	 indicates	 that	
they	constitute	distinct	biophysical	patterns	of	variation	across	subjects;	 for	example,	mode	7	correlates	with	
age,	while	mode	9	does	not.	The	broader	range	of	non-imaging	measures	involved	in	mode	9,	and	the	ability	to	
interpret	many	of	them	in	terms	of	positive	or	negative	life	factors,	is	reminiscent	of	the	single	mode	previously	
reported	 from	HCP	 data
8,	 34
.	 That	mode	 resembled	 the well-established observation	 of	 strong	 correlations in	
subject	performance	across	a	broad	range	of	cognitive	and	behavioral	tests	(the	“general	intelligence”	g-factor),	
but	also	included	demographic	and	life	factors. However,	there	is	not	perfect	correspondence	between	mode	9	
reported	here	and	the	previous	HCP	mode.	This	may	be	due	to	key	differences	in	the	HCP	and	Biobank	datasets,	
including	different	non-imaging	measures,	the	use	of	only	rfMRI	in	the	HCP	analysis,	the	different	cohort	profiles
(e.g.,	age	range)	and	the	ability	to	separate	more	modes	from	the	larger	Biobank	cohort.
Illustrative	hypothesis-driven	study
The	Austrian	Stroke	Prevention	Study	(ASPS) recently	reported	associations	between	aging, smoking	and	body	
mass	index	(BMI) with	gray	matter	T2*	in	314	participants	(38-82	years)
38
,	likely	reflecting	iron	accumulation	in	
local	 tissue
13
.	 We sought	 to	 replicate	 several	 of	 their	 key	 findings as	 a	 demonstration	 of	 a	 hypothesis-led	
investigation.	The	ASPS	study	reported R2*,	which	is	the	reciprocal	of	the	T2*	value	we	estimate	in	UK	Biobank;
therefore we	expected T2*	associations	with opposite	sign	 to	 those	 reported	by	ASPS. The	main	 results	 from	
ASPS	in	deep	gray	matter	structures	were	as	follows:	BMI	was	the	strongest	determinant	of	R2*	generally,	and	
was	significantly	related	to	R2*	in	amygdala	(beta=0.23, PFDR=0.009)	and	hippocampus	(beta=0.14, PFDR<0.0001).	
Further	 associations	 with	 R2*	 (averaged	 across	 subcortical	 structures)	 were	 found	 for	 age	 (beta=0.03,	 PFDR
=0.027)	 and	 recent	 smoking	 level	 (beta=0.02,	 PFDR=0.001).	 No	 equivalent	 associations	were	 found	 for	 sex	 or	
hypertension. The	ASPS	conducted	univariate	correlations	and	multiple	regressions	to	identify	both	shared	and	
unique	 variance	 in	 the	 associations,	 using	 FDR	 correction.	 Based	 on	 these	 results,	 we	 hypothesize	 negative	
association	between	T2*	in	subcortical	structures	with	BMI,	age	and	smoking.
We	conducted	similar	analyses,	applying	univariate	correlations	and	multiple	regressions	against	a	similar	set	of	
covariates	to	ASPS	 (see	Fig	8). The	regressions	used	 the	n=4,891	subjects	with	complete	data	 in	all	 IDPs	and	
covariates.	 In	 order	 to	 maximize	 the	 complementarity	 of	 information	 content	 between	 the univariate
correlations	 and	 multiple	 regressions,	 no	 adjustments	 for	 factors	 such	 as	 age	 and	 sex	 were	 applied	 in	
correlations,	whereas	 these	 factors	were	included	as	 confound covariates	 in	 the multivariate regressions. We	
applied	 Bonferroni multiple	 comparisons correction across	 covariates	 and	 brain	 regions,	 resulting	 (for	
Pcorrected<0.05)	in	a	-log10Puncorrected		threshold	of	3.6.
Our	results were	highly	concordant	with	ASPS.	BMI was	significantly	associated	with	T2*	in	amygdala	(averaged	
across	 left	 and	 right:	 beta=-0.07, -log10Puncorrected=3.9)	 and	 hippocampus	 (beta=-0.15, -log10Puncorrected=17.0; for
comparison,	FDR	correction	would	result	in	PFDR<10
-10
).	Individual	subcortical	BMI	associations	are	shown	in	Fig	
8b.	In	accordance	with	our	hypothesis,	the	signs	of	regression	betas	are universally	negative	with	T2*	from	UK	
Biobank	data.	Associations	with	T2*	were	found	for	age	in	thalamus,	caudate	and	putamen	(see	Fig	8c)	and	for	
smoking	status	in	caudate,	putamen	and	right	pallidum	(beta	ranging	from	-0.03	to	-0.1). Association	of	T2*	with
sex	was	only	found	in	right	amygdala,	and	no	association	was	found	for	hypertension.
The	 increased	 specificity	 of	multiple	 regression	 is	 notable	 for	many	 of	 the	 tests –	 for	 example,	 a	 significant	
univariate	association	of	T2*	with	cholesterol	disappears	after	controlling	for	the	other	covariates.	Similarly,	for	
T2*	in	hippocampus	and	amygdala,	many	of	the	associations	with	age,	sex,	BMI	and	other	factors	become	much	
weaker	after	controlling	for	all	variables,	in	particular	amount	of	head	motion.	Despite	the	fact	that	this	motion	
was	recorded	 from	the	 functional	data	 (not	 the	T2*	data),	 it	 is	 likely	 a	 general	 indicator	 of	 head	motion,	 and	
these	 results	 illustrate	why interpretation	 of imaging	 associations	 requires	 care.	 For	 example,	 BMI could	 be	
predictive	of	head	motion	(e.g.,	comfort	in	the	scanner)	while	also	potentially	relating	to	biophysical	parameters	
of	deeper	interest.
The	 BMI	 and	 smoking	 associations	 with	 T2*	 are	 found	 in	 distinct	 subcortical	 structures.	 Interestingly,	 this	
distinction	is	reflected	in	the	CCA-ICA	results,	where	 these	associations	appear	 in	separate	population	modes.
The	association	of	T2*	in	caudate	and	putamen	with	smoking	(and	more	weakly	with	alcohol,	Fig	8c)	is	highly	
7concordant	 with	 CCA-ICA	 mode	 5	 (Supplementary Fig	 4b),	 and	 is	 associated	 with aging	 (Fig	 8c	 and	
Supplementary Fig	8).	The	association	of	T2*	 in	hippocampus	 and	 amygdala	with	BMI	 is	 highly	 concordant	
with	CCA-ICA	mode	3	(Supplementary Fig	3c),	a	distinct	mode	of	population	covariation	that is	not	associated	
with	 aging	 (in	 either	 analysis).	 Neither	 mode	 includes	 cognitive	 test	 scores,	 suggesting	 that	 while	 these	
associations	clearly	relate	to	biological	processes,	they may be	only	indirectly	linked	to	cognitive	health.
DISCUSSION
Challenges	of	population	imaging
UK	Biobank	data	 is	 openly	 available	 to	 researchers	 including	 non-imaging	 experts.	However,	 imaging	 data	 is	
considerably	 more	 complex	 than	 most	 of	 the	 existing	 UK	 Biobank	 measures.	 Extensive	 post-processing	 is	
required	to	align	images	across	subjects	and	remove	artefacts.	Moreover,	information	is	usually	encoded	across	
multiple	voxels,	 requiring	 further	 processing	 to	 extract	 relevant	 features.	 Even	with	 carefully-prepared	 IDPs,	
meaningful	interpretation	requires	care because MRI	is	generally	an	indirect	measure	of	the	biology	of	interest.	
Apparent	structural	atrophy	can	be susceptible	to	misinterpretation
39
;	functional	MRI	signals	can	reflect	vascular	
properties	rather	than	neural	activity
40
;	and	diffusion	MRI	is	sensitive	to	many	aspects	of tissue	microstructure
14
.	
A	 final	 challenge	 is	 that data	 sizes	 have	 become	 extremely	 large,	 requiring	 “big	 data”	 techniques;	 the	 brain	
imaging	data	in	UK	Biobank will	ultimately surpass 0.2PB	even	without	data	inflation	during	post-processing.
Large	cohorts	face	the	further	challenge	that	statistically	significant	associations	are	identified	even	when	their	
explanatory	power	is	small.	In	the	present	dataset,	significance	is	reached	at	a	correlation	of	just	r≈0.1,	i.e.,	1%	of	
population	 variance	 explained
41
even	 with	 multiple	 comparison	 correction.	 Large	 genome-wide	 association	
studies	(GWAS)	face	this	challenge,	where	it	 is	accepted	that	small	effect	sizes	can	be	meaningful,	particularly	
where	multiple	factors	combine	to	create	a	large	effect.	However,	in	GWAS,	genetic	variants	can	be	interpreted	
as	 causal	 factors	 (whether	 direct	 or	 indirect
42
),	 whereas	 apparent	 associations	 across	 IDPs	 and	 non-imaging	
phenotypes	could	result	from	a	shared	latent	(non-measured)	cause.	For	example,	education	level	could	result	in	
a	dietary	 factor	associating	with	a	brain	IDP,	despite	no	 direct	 causal	 connection	 between	diet	 and	 IDP.	 This	
danger	is	inflated	with	larger	subject	numbers,	but	may	here	be	mitigated	by	the	rich	life	factor	and	biological	
variables	that	can	be	controlled	for	or	used	to	match	sub-groups. Population	variances	explained	in	the	pairwise	
associations	reached	maxima	of	around	5%	(Supplementary	Fig	2),	but	these	are	higher	with	the	multivariate	
analyses	 (up	 to	 20-50%	variance	 explained	 in	 the	most	 highly	 involved	 variables	within	 population	modes),	
partly	reflecting	increased	sensitivity	gained	when	appropriately	combining	across	related	variables.
The	importance	of	accounting	for	relevant	confounds	is	exemplified	in	Fig	6e,	which	shows	a	strong	apparent	
association	between	total	white	matter	volume	and	fat-free	body	mass	(one	scatter	point	per	subject)	without	de-
confounding.	 In	 fact,	 this	association	 is	 largely	driven	by	the	 average	 differences	 in	 body	mass	 and	head	 size	
between	sexes	(see	color	coding)	and	disappears after	adjusting	for	sex,	age	and	head	size.	This	is	an	example	of	
Simpson’s	 paradox
43
,	 in	 which	 suboptimal	 pooling	 across	 variables	 (here, sex)	 results	 in	 a	 misleading	
association.	 Other	 pitfalls	 include	 failing	 to	 consider	 study	 population	 selection	 bias
44
and	 inappropriate	de-
confounding	of	variables	that	are	caused	by	(and	not	feeding	into)	the	variables	of	 interest
45
.	While	there	is	no	
guarantee	that	UK	Biobank	is	an	unbiased	sample	of	the	full	population,	that	does	not	 imply	that	studies	using	
subsets	of	the	data	have	to	retain	any	biases	(though	again	it	is	still	possible	for	bias	to	arise
44
);	one	important	
aspect	of	study	design	will	be	the	method	of sub-selection	of	Biobank subjects	to	feed	into	an	analysis.	In	the	case	
of	 focused	hypothesis	 testing,	 it	 is	 likely	 that	 carefully	 selected	 sub-groups	 of	 subjects	 should	 be	 utilized.	 For	
example,	once	a	group	of	subjects	 is	 identified	with	a	clinical	diagnosis,	 it	is	 likely	that	optimal	sensitivity	and	
interpretability	 will	 require	 a	 control	 sub-group	 that	 is	 matched	 over	 many	 relevant	 factors	 (e.g.	 sex,	 age,	
relevant	life	factors	not	appearing	in	the	predictive	model).
Future	studies	might	seek	to	find	causalities	between	variables,	for	example	using	structural	equation	modeling,	
Bayes	 Nets	 or	 non-linear/non-Gaussian	 methods
46
.	 The	 dangers	 of	 inferring	 causalities	 from	 observational	
datasets	like	UK	Biobank	are	well-known; the	inclusion	of	genotype	and	other	“instrumental” measures	enable
analyses	such	as	Mendelian	randomization,	although	important	caveats	must	be	considered
42
. The	safest	way	to	
confirm	causal	results	discovered	from	such	observational	datasets	is	to	use	such	results	to	form	hypotheses	for	
new	focused	interventional	studies.
The	 mapping	 of	 disease	 associations	 and	 population	 patterns	 (e.g.,	 learned	 from	 UK	 Biobank	 data)	 onto	
individuals	will	be	an	important	long-term	goal.	For	example,	population	distributions	of	imaging	measures	and	
health	outcomes	can	be	learned,	and	used	to	form	patient-specific	prior	distributions	to	combine	with	measures	
from	 a	 new	 patient.	 While	 this	 might	 not	 provide	 statistical	 certainty	 for	 a	 diagnosis	 or interventional	
recommendation,	it	should	allow	for	single-patient	imaging	to	be	used	in	a	similar	way	to current state-of-the-art
patient-tuned	genetic	testing.
8Data	analysis	in	population	imaging
The	analyses	presented	here	demonstrate	some	of	the	possibilities	offered	by	the	UK	Biobank resource.	Focused
association	studies	may	select	just	two	variables	to	investigate,	for	example,	one	IDP	correlated	against	one	life	
factor,	genetic	marker,	physical	assay	or	health	outcome.	More	complex	analyses	could	model a	larger	number	of	
variables	simultaneously,	for	example,	looking	to	predict	health	outcome	from	multiple	linear	regression	against	
several	 predictor	 variables. Nonlinear	 methods	 (e.g.	 penalized	 regression	 or	 data-driven	 feature selection)
22
could	 enable	 use	 of	much	 larger	 number	 of	 predictor	 variables.	 A	 further	 extension could	 identify	 nonlinear	
interactions	 between	 predictor	 variables,	 for	 example	 considering	 an	 imaging	 measure,	 a	 life	 factor	 and	 an	
interaction	 term	between	 the	 two	 as	 three	 distinct	 predictors.	 An	 even	more	 complex	 analysis	might	 predict
multiple	 outcome	 variables,	 looking	 for	 “doubly-multivariate”	 associations	 between	 two	 or	 more	 sets	 of	
variables;	the	CCA-ICA	analyses	presented	above	are	an	example	of	this.	Finally,	imaging	measures	may	in	some	
cases	be	more	sensitive	or	specific	than	clinical	symptoms
47
,	thereby	providing	proxies	for	healthcare	outcomes
and/or	enabling	clustering	of	patients	that	is	more	predictive	of	prognosis	or	therapeutic	response
48
.
Pairwise	correlation	analyses	result	in	simple	outcomes	that	require	an	understanding	of	the	caveats	in	imaging-
derived	measures. Data-driven	multivariate	 analyses	 identifying	 associations	 between	 sets	 of	 variables	 have	
complementary	benefits,	including improved	sensitivity	to	biological	processes	and a	streamlined	set	of	results
compared	with	millions	of	univariate	associations.	Further, multivariate	analyses	can separate distinct	biological	
processes	with	opposing	relationships	between	variables.	For	example,	our	CCA-ICA	analysis	revealed	one	aging-
related	process	 that	 involved	changes	 in	heart	 rate	and	 fMRI	measures	 (mode	4)	while	 another	 aging-related	
process	related	blood	pressure	and	white	matter	microstructure	(mode	8).	A	simple	correlational	analysis	would	
show	associations	between	all	of	these factors,	including	even	those	that	appeared	in	separate	modes	(e.g.	fMRI	
and	white	matter	 changes).	 Additionally,	 as	with	multiple	 regression,	 simultaneous	 identification	 of	multiple	
modes	of	association	reduces	the	unexplained	residual	variance	(effectively	data	“de-noising”).
Multivariate	 analyses	 of	multi-modal	 data	 like	 UK	 Biobank	 enable	 discovery	 of	 (potentially	 complex)	 clinical	
phenotypes.	This	is	a	powerful	alternative	to	diagnostic	categories	that	rely	on	clinical	symptoms	which	do	not	
map	 cleanly	 onto	 underlying	 disease	 mechanisms. For	 many	 complex	 diseases,	 the	 discovery	 of	 distinct	
mechanisms/sub-diseases	that	are	currently	conflated	may	be	unlikely	to	occur	solely	through	symptom-based	
investigations.	 Discovering	 relevant	 population	 axes	 and	 sub-groups	 based	 on	 imaging,	 genetics	 and	 other	
objective	markers	may	therefore	be	expected	to	increase	our	understanding	of	the	etiology	and	pathogenesis	of	a	
wide	variety	of	diseases.	For	example,	 this	 concept	 is	at	 the	 heart	 of	 the	 recently-proposed	Research	Domain	
Criteria	(RDoC)	in	psychiatry
48
.
Population	imaging	landscape
In	 the	 early	 2000s,	 several ambitious	 studies	 built	 cohorts	 numbering thousands	 of	 subjects.	 	 Several	 recent
brain	 imaging	 studies	 are	 aiming	 to	 image	 tens	 of	 thousands	 of	 subjects,	 including	 the	 Maastricht	 Study	
(n=10,000)
49
,	 the	 German	 National	 Cohort	 (n=30,000)
50
	 and	 the	 Rhineland	 Study	 (n=30,000).	 In	 addition	 to	
having	even	larger	numbers,	UK	Biobank will	benefit	from	the	breadth	of	organ	systems	imaged,	the	highly	multi-
modal	brain	protocol,	and	the	existing	rich	phenotyping. A	longitudinal	component	is	planned	for	a	subset	of	the
UK	Biobank imaging	participants (n=10,000),	as	 in	 the	Rhineland and	GNC	 studies.	Most	 of	 these	 studies	 use
identical	MRI	 scanners	 at	 a	 small	 number	 of	 dedicated	 sites,	 with	 the	 goal	 of	maximizing	 data	 homogeneity
within	study.	A	future	challenge	to	further	leveraging	these	large	datasets	is	to	develop	analysis	tools	that	can	
harmonize	 data	 across	 these	 studies	 for	 combined	 analyses,	 where	 there	 could	 be	 considerable	 impact	 in	
focusing	on	harmonization	of	a	few	very	large	cohorts.
Even	with	just	5%	of	the	eventual	cohort	size,	the	results	presented	here	demonstrate	the	statistical	benefits	that	
are	conferred	by	large	numbers.	However,	the	primary	rationale	for	the	size	of	the	study	is	not	to	boost	statistical	
power	across	100,000	subjects,	but	 rather	 to	 provide	prospective	 imaging	 data	 suitable	 for	 discovering	 early	
markers	and	risk	factors	for	as	broad	a	set	of	diseases	as	possible.	For	some	rare	diseases	with	few	established	
risk	 factors,	 this	 approach	 is	 uniquely	 suited	 to	 discovery	 of	 pre-symptomatic	markers;	 for	 example,	 50-100
imaging participants	are	expected	 to	develop	sporadic	amyotrophic	 lateral	 sclerosis	 (ALS)	 by	 2027.	 This	 rich	
imaging	addition	to	the	ongoing	UK	Biobank	study	will	provide	scientists	with	novel	insights	into	the	causes	of	
brain	disease,	provide	markers	with	predictive	power	for	therapeutic	 interventions,	and	advance	non-invasive	
imaging-based	screening	for	preventative	healthcare.
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Figure	captions
Figure	 1	 	Data	 from	 the	 three	 structural	 imaging	modalities	 in	 UK	 Biobank	 brain	 imaging.	 (a)	 Single-subject	T1-
weighted	 structural	 image	with minimal	 pre-processing:	 removal	 of	 intensity	 inhomogeneity, lower	neck	 areas	 cropped	
and	 the	 face	 blanked	 to	 protect	 anonymity.	 Color	 overlays	 show	 automated	modeling	 of	 several	 subcortical	 structures	
(above)	and	segmentation	of	gray	matter	(below).	(b)	Single-subject	T2-weighted	FLAIR	image	with	the	same	minimal	pre-
processing,	showing hyperintense	lesions	in	the	white	matter	indicated	(arrows).	(c)	Group-average	(n≈4500)	T1	atlas;	all
subjects’	data	were aligned	together (see	Online	Methods	 for	processing	details)	and	 averaged,	 achieving higher	quality	
alignment,	with	clear	delineation	of	deep	grey	structures	and	good	agreement	of	major	sulcal	folding	patterns	despite	wide	
variation	in	these	features	across	subjects.	(d)	Group-average	T2	FLAIR	atlas.	 (e)	Group-average	atlas	derived	 from	SWI	
processing	of	swMRI	phase	 and	magnitude	 images.	 (f)	Group-average	T2*	 atlas,	also	derived	 from	 the	 swMRI	 data.	 (g)	
“Manhattan”	plot	 (a	 layout	common	 in	genetic	studies)	relating	all	25	 IDPs	 from	the	T1	data	 to	1100	non-brain-imaging	
variables	extracted	from	the	UK	Biobank	database,	with	 the	 latter	 arranged	 into	major	 variable	 groups	 along	 the	 x	 axis
(with	 these	 groups	 separated	 by	 vertical	 dotted	 lines).	 For	 each	 of	 these	 1100	 variables,	 the	 significance	 of	 the	cross-
subject	univariate	correlation	with	each	of	the	IDPs	is	plotted	vertically,	in	units	of	–log10(Puncorrected).	The	dotted	horizontal	
lines	 indicate	 thresholds	 corresponding	 to	 multiple	 comparison	 correction	 using	 false	 discovery	 rate	 (FDR,	 lower	 line,	
corresponding	to	puncorrected=3.8×10
-5
)	and	Bonferroni	correction	(upper	line,	puncorrected=1.8×10
-8
)	across	the	2.8	million	tests	
involving	correlations	of	all	modalities’	IDPs	against	all	1100	non-imaging	measures.	Effects	such	as	age,	sex	and	head	size	
are	regressed	out	of	all	data	before	computing	the	correlations.	As	an	indication	of	the	corresponding	range	of	effect	sizes,	
the	maximum	r2	 (fractional	 variance	of	 either	 variable	 explained	by	 the	 other)	 is	 calculated,	 as	well	 as	 the	minimum	 r2
across	all	tests	passing	the	Bonferroni	correction.	Here	the	maximum	r2	=	0.045	and	the	minimum	r2	=	0.0058.	See	Online	
Methods	for	more	details	of	these	analyses.	(h)	Plot	relating	all	14	T2*	IDPs	to	1100	non-imaging	variables.	Maximum	r2	=	
0.034,	minimum	r2	=	0.0063.	Marked	Bonferroni	and	FDR	multiple	comparison	threshold	levels	are	the	same	as	in	(g).
Figure	2		 	The	diffusion	MRI	data	in	UK	Biobank.	(a)	Group-average	(n≈4500)	atlases	from	six	distinct	dMRI	modeling	
outputs,	 each	 sensitive	 to	 different	 aspects	 of	 the	 white	 matter	 microarchitecture.	 See	 Online	 Methods	 for	 processing	
details.	 The	 atlases	 shown	 are:	 FA	 (fractional	 anisotropy),	 MD	 (mean	 diffusivity)	 and	 MO	 (tensor	 mode);	 ICVF	(intra-
cellular	volume	fraction),	ISOVF	(isotropic	or	free	water	volume	fraction)	and	OD	(orientation	dispersion	index),	from	the	
NODDI	microstructural	modeling.	Also	shown	are	several	group-average	white	matter	masks	used	to	generate	 IDPs	(e.g.,	
pink	 (r)	 are	 retrolenticular	 tracts	 in	 the	 internal	 capsules;	 upper-green	 (s)	 are	 the	 superior	 longitudinal	 fasciculi).	 (b)	
Tensor	ellipsoids	depicting	the	group-averaged	tensor	fit	at	each	voxel	for	the	region	shown	inset	in	(c).	The	shapes	of	the	
ellipsoids	 indicate	 the	 strength	 of	 water	 diffusion	 along	 three	 principal	 directions;	 long	 thin	 tensors	 indicate	 single	
dominant	fiber	bundles,	whereas	more	spherical	tensors	(within	white	matter)	generally	imply	regions	of	crossing	fibers	
(seen	 more	 explicitly	 modeled	 in	 corresponding	 parts	 of	 (c)).	 (c)	 Group-averaged	 multiple	 fiber	 orientation	 atlases,	
showing	up	to	3	fiber	bundles	per	voxel.	Red	shows	the	strongest	fiber	direction,	green	the	second,	and	blue	the	third.	Each	
fiber	bundle	is	only	shown	where	the	modeling	estimates	that	population	to	have	greater	than	5%	voxel	occupancy.	Inset	
shows	 the	 thresholded mean	 FA	 image	 (copper)	 overlaid	 on	 the	 T1,	 with	 the	 region	 shown	 in	 detail	 in	 (b)	 and	 c)	
highlighted.	(d)	Four	example	group-average	white	matter	tract	atlases	estimated	by	probabilistic	tractography	 fed	 from	
the	within-voxel	fiber	modeling:	corpus	callosum	(genu),	superior	 longitudinal	 fasciculus,	corticospinal	 tract	and	 inferior	
fronto-occipital	fasciculus.	(e)	Plot	relating	all	675	dMRI	IDPs	(nine	distinct	dMRI	modeling	outputs	from	tensor	and	NODDI	
models	×	75	tract	masks)	to	1100	non-imaging	variables	(see	Fig	1g	for	details). Maximum	r2	=	0.057,	minimum	r2	(passing	
Bonferroni)	=	0.0065. Dotted	horizontal	lines	(multiple	comparison	thresholds)	are	the	same	as	in	Fig	1g.
Figure	3			The	task	fMRI	data	in	UK	Biobank.	(a)	The	task	paradigm	temporal	model	(time	running	vertically)	depicting	
the	 periods	 of	 the	 two	 task	 types	 (shapes	 and	 faces);	 for	 more	 information	 on	 this	 paradigm	 view,	 see	
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FEAT/UserGuide.	 (b)	Example	 fitted	 activation	 regression	model	 vs. timeseries	data	
(time	 running	 horizontally),	 for	 the	 voxel	most	 strongly	 responding	 to	 the	 “faces	 >	 shapes”	 contrast	 in	 a	 single	 subject	
(Z=12.3).	(c)	Percentage	of	subjects	passing	simple	voxel-wise	activation	thresholding	(Z>1.96)	for	the	same	contrast.	Note	
reliable	focal	activation	in	left	and	right	amygdala.	The	underlying	image	is	the	group-averaged	raw	fMRI	image.	(d)	Group-
averaged	 activation	 for	 the	 3	 contrasts	 of	 most	 interest,	 overlaid	 on	 the	 group-average	 T1	 atlas	 (fixed-effects	 group	
average,	Z>100,	voxelwise Pcorrected<10
-30
).	(e)	Plot	relating	the	16	tfMRI	IDPs	to	1100	non-imaging	variables	(see	Fig	1g	for	
details). Maximum	 r2	 =	 0.018,	minimum	 r2	 (passing	Bonferroni)	 =	0.0062. Dotted	horizontal	 lines	 (multiple	 comparison	
thresholds)	are	the	same	as	in	Fig	1g.
Figure	4			The	resting-state	fMRI	data	in	UK	Biobank.	 (a)	Example	group-average	resting-state	network	(RSN)	atlases	
from	 the	 low-dimensional	 group-average	 decomposition,	 showing	 four	 out	 of	 21	 estimated	 functional	 brain	 networks,
including	the	default	mode	network	(red-yellow),	dorsal	attention	network	(green),	primary	visual	(copper),	 and	higher	
level	visual	(dorsal	and	ventral	streams,	blue).	The	three	slices	shown	are	(top	to	bottom)	sagittal,	coronal	and	axial.	(b)	
The	55	non-artefact	 components	 from	a	higher-dimensional	 parcelation	 of	 the	 brain	 (axial	 views).	 These	 are	 shown	 as	
displayed	by	 the	 connectome	browser	 (www.fmrib.ox.ac.uk/analysis/techrep/ukb/netjs_d100),	which	 allows	 interactive	
investigation	of	individual	connections	in	the	group-averaged	functional	network	modeling.	The	55	brain	regions	(network	
nodes)	 are	 clustered	 into	 groups	 according	 to	 their	 average	 population	 connectivity,	 and	 the	 strongest	 individual	
connections	are	shown	(positive	in	red,	anticorrelations	in	blue).	(c)	Plot	relating	the	76	rfMRI	“node	amplitude”	 IDPs	 to	
1100	non-imaging	variables	(see	Fig	1g	for	details).	Maximum	r2	=	0.065,	minimum	r2	(passing	Bonferroni)	=	0.0059.	(d)	
Plot	relating	the	1695	rfMRI	“functional	connectivity”	IDPs	to	1100	non-imaging	variables. Maximum	r2	=	0.032,	minimum	
r2	=	0.0059. Dotted	horizontal	lines	(multiple	comparison	thresholds)	in	(c)	and	(d)	are	the	same	as	in	Fig	1g.
Figure	5			Voxel-wise	correlations	of	participants’	age	against	several	white	matter	measures	from	the	dMRI	and	T2	
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FLAIR	data.	(a)	Voxel-wise	(cross-subject)	correlation	of	FA	(fractional	anisotropy)	vs.	age.	Group-average	FA	in	white	
matter	is	shown	in	green,	overlaid	onto	the	group-average	T1.	(b)	Correlation	of	MO	(tensor	mode)	vs.	age,	using	the	same	
color	scheme.	Nearby	areas	of	MO	increase	are	shown	in	greater	detail	in	(f),	which	also	shows	the	distinct	primary	fiber	
directions.	(c)	Correlation	of	OD	(orientation	dispersion)	vs.	age,	including	a	reduction	in	dispersion	in	posterior	corpus	
callosum.	(d)	Correlation	of	ISOVF	(isotropic	or	free	water	volume	fraction)	vs.	age,	showing	increases	in	“free	water”	with	
age	in	a	broad	range	of	tracts.	(e)	Voxel-wise	correlation	of	T2	FLAIR	intensity,	showing	increased	intensity	with	aging	in	
white	matter.	For	(a-e),	blue	and	red-yellow	show	negative	and	positive	Pearson	correlation	with	age,	respectively
(Pcorrected<0.05,	with	Bonferroni	correction	across	voxels	resulting	in	significance	at	r=0.1	(dMRI n=3722;	T2	FLAIR	n=3781).	
(g)	Histograms	(across	voxels)	of	the	voxel-wise	age	correlation	of	the	correlation	maps	shown	above,	with	correlation	
value	on	the	x	axis.	FA	and	MO	largely	decrease	with	age,	while	OD	and	ISOVF	largely	increase.
Figure	6			Visualisation	of	2.8	million	univariate	cross-subject	association	tests	between	2501	IDPs	and	1100	other	
variables	in	the	UK	Biobank	database. (a)	Manhattan	plot	showing,	for	each	of	the	1100	non-brain-imaging	variables,	the	
statistically	strongest	association	of	that	variable	with	each	distinct	imaging	sub-modality’s	IDPs.	(i.e.,	6	results	plotted	for	
each	x	axis	position,	each	with	a	color	indicating	a	brain	imaging	modality;	this	plot	differs	from	the	other	Manhattan	plots,	
which	 show	correlations	with	all	 IDPs).	Whereas	 the	Manhattan	 plots	 in	Figs	 1-4	 indicated	 associations	 for	 each	 brain	
imaging	modality	separately,	here	we	depict	all	associations	in	a	single	plot.	(b)	List	of	all	IDP-cognitive	score	associations	
passing	Bonferroni	correction	 for	multiple	 comparisons	 (Pcorrected<0.05;	 Puncorrected<1.8x10
-8
).	 The	 first	 column	 lists	 the	age-
adjusted	 correlation	 coefficient,	 and	 the	 second	 shows	 the	 unadjusted	 correlation,	 both	 being	 correlations	 between	 a	
specific	brain	IDP	(fifth	column)	and	a	cognitive	test	score	(seventh	column).	UK	Biobank	cognitive	tests	carried	out	include	
Fluid	Intelligence,	Prospective	Memory,	Reaction	Time	(Shape	Pairs	Matching),	Memorised	Pairs	Matching,	Trail	Making	
(Symbol	Ordering),	 Symbol	Digit	 Substitution,	 and	Numeric	Memory.	 (c)	 IDP	 associations	with	 the	 cognitive	 phenotype	
variables	(the	full	set	of	174	cognitive	variables,	repeated	for	each	brain	imaging	modality).	Shown	behind,	in	gray,	are	the	
same	 associations	 without	 adjustment	 for	 age,	 with	 a	 large	 number	 of	 stronger	 associations. Dotted	 horizontal	 lines	
(multiple	comparison	thresholds)	in	(a)	and	(c)	are	the	same	as	in	Fig	1g. (d)	Scatterplot	showing	the	relationship	between	
adjusted	correlations	and	those	obtained	without	first	regressing	out	the	confound	variables	(each	point	is	a	pairing	of	one	
IDP	with	one	non-brain-imaging	variable,	2.8	million	points).	The	grid	lines	indicate	Bonferroni-corrected	significance	level
(as	described	in	Fig	1).	(e)	Example	association	between	unadjusted	white	matter	volume	and	fat-free	body	mass	 is	high	
(r=0.56)	when	pooling	across	the	sexes.	After	adjusting	for	several	variables	(including	sex),	the	correlation	falls	almost	to	
zero.
Figure	 7	 	 	 Details	 of	 three	modes	 from	 the	 doubly-multivariate	 CCA-ICA	 analyses	 across	 all	 IDPs	 and	non-brain-
imaging	variables.	 IDPs	are	 listed	 in	orange	and	non-brain-imaging	variables	 in	black.	The	text	 lists	show	 the	 variables	
most	strongly	associated	with	each	mode;	where	multiple	very	similar	(and	highly	correlated)	non-imaging	variables	are	
found,	only	the	most	significant	is	listed	here	for	brevity.	The	first	column	shows	the	weight	(strength	and	sign)	of	a	given	
variable	in	the	ICA	mode,	the	second	shows	the	(cross-subject)	percentage	variance	of	the	data	explained	by	this	mode,	and	
the	third	column	shows	the	percentage	variance	explained	in	the	data	without	the	confounds	first	regressed	out.	Mode	7	
links	 measures	 of	 bone	 density,	 brain	 structure/tissue	 volumes	 and	 cognitive	 tests.	Mode	 8	 links	 measures	 of	 blood	
pressure	 and	 alcohol	 intake	 to	 IDPs	 from	 the	 diffusion	 and	 functional	 connectivity	 data;	 two	 functional	 network	
connections	strongly	involved	are	displayed,	with	the	population	mean	connection	indicated	by	the	bar	connecting	the	two	
nodes	forming	the	connection	(red	indicates	positive	mean	correlation,	blue	negative,	and	the	width	of	the	bar	indicates	the	
connection	strength).	The	group-ICA	maps	are	thresholded	at	Z>5,	and	the	colored	text	is	the	ICA	weight	shown	in	the	table	
list.	Mode	9	includes	a	wide	range	of	imaging	and	non-imaging	variables	(see	main	text	for	details);	as	well	as	showing	3	
strong	 functional	 network	 connections,	 we	 also	 show	 two	 functional	 nodes	 whose	 resting	 fluctuation	 amplitude	 is	
associated	with	this	mode.
Figure	 8	 	 	 Hypothesis-driven	 study	 of	 age,	 BMI	 and	 smoking	 associations	 with	 subcortical	 T2*. (a)	 UK	 Biobank
population-average	map	 of	 T2*,	 overlaid	with	 the	main	 subcortical	 structures	 being	 investigated.	 The	 T2*	 IDPs	 reflect	
individuals’	median	T2*	values	within	these	regions.	The	relatively	low	T2*	in	putamen	and	pallidum	likely	reflects	greater	
iron	content.	(b)	BMI	regression	betas	from	multiple	regressions	of	R2*	(from	the	ASPS	study)	and	T2*	(from	UK	Biobank)	
against	 relevant	 covariates	 (see	 (c)).	 All	 variables	 are	 standardized	 so	 that	 beta	 values	 can	 be	 interpreted	 as	 (partial)	
correlation	coefficients.	R2*	significance	is	reported	as	FDR-corrected	P.	T2*	significance	is	reported	as	–log10Puncorrected	with	
the	more	conservative	Bonferroni	correction	(for	Pcorrected=0.05)	resulting	in	a	threshold	here	of	3.6.	(c)	Full	set	of	univariate
and	multiple	regression	betas	and	significance	values	for	all	brain	regions	tested	and	all	model	covariates.	The	regression	
results	are	much	sparser,	reflecting	the	higher	associational	specificity	obtained	by	reporting	unique	variance	explained.
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ONLINE	METHODS	
Protocol	Overview
Imaging	 protocols	were	 designed	 by	 the	UK	 Biobank	 Imaging	Working	 Group	(www.ukbiobank.ac.uk/expert-
working-groups),	in	consultation	with	a	large	number	of	brain	imaging	experts	(listed	in	the	acknowledgments).	
MRI	 provides	 many	 imaging	 modalities	 offering	 complementary	 information.	 As	 part	 of	 this	 consultancy,	 a	
number	of	modalities	were	determined	to	be	infeasible	or	lower	priority	for	a	range	of	reasons.	Considerations	
included	time	constraints,	generalizability,	feasibility	of	automated	analysis,	and	existence	of		robust,	well-tested	
acquisition	 methods.	 The	 advisory	 network	 therefore	 decided	 not	 to	 include	 quantitative	 relaxometry,	 MR	
spectroscopy	or	angiography.	Arterial	spin	labeling	is	currently	being	piloted,	as	described	below.
To	 maximize	 data	 compatibility,	 three	 dedicated	 imaging	 centers	 will	 have	 identical	 scanners	 with	 fixed	
platforms	(i.e.,	no	major	software	or	hardware	updates	throughout	the	study).	Each	center	is	equipped	with	a	3T	
Siemens	Skyra	(software	platform	VD13),	1.5T	Siemens	Aera	(VD13),	carotid	ultrasound	and	dual	energy	X-ray	
absorptiometry	(DEXA).	Brain	imaging	is	being	conducted	on	the	3T	system	using	a	32-channel	receive	head	coil.
Key	acquisition	parameters	for	each	modality	are	summarized	in	Supplementary	Table	1,	grouped	according	to	
primary	modality	categories	 (structural,	diffusion	and	 functional	MRI).	Order	of	 acquisition	was	 optimized	 in	
consideration	 of	 subject	 compliance,	 assuming	 subject	 motion	 might	 increase	 over	 the	 scan	 (favoring	 early	
acquisition	of	the	T1	due	to	its	central	importance	–	for	example	the	processing	pipeline	cannot	run	without	the	
T1)	and	subject	wakefulness	might	decrease	(favoring	early	acquisition	of	fMRI).	The	order	is:	(1)	T1,	(2)	resting	
fMRI,	(3)	task	fMRI,	(4)	T2	FLAIR,	(5)	dMRI,	(6)	swMRI.
Further	 protocol	 details	 are	 available	 at:	 http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=2367 and further
description	 of	 post-processing	 pipelines	 and	 data	 outputs	 included	 in	 the	 first	 data	 release	 are	 available	 at:	
http://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf.	 All	 software	 used	 in	 these	 pipelines	 is	 freely	
available
51,	52
	and	full	pipeline	processing	scripts	will	shortly	be	publicly	available.
The	processing	pipeline	utilized	for	the	initial	data	release	was	primarily	based	on	tools	from	FSL	(the	FMRIB	
Software	Library
51
),	but	it	will	be	gradually	expanded	to	utilize	a	broader	range	of	methods	and	software,	where	
this	will	increase	the	quality,	robustness	and	scope	of	IDPs	generated.	For	example,	one	high	priority	is	to	adapt	
the	Human	Connectome	Project	pipelines
53
	to	provide	cortical	surface	modeling.
The	intention	is	that	non-imaging	experts	will	be	able	to	use	the	IDPs	directly	without	having	to	become	expert	
in	the	complexities	of	data	processing,	although	we	encourage	engagement	with	imaging	experts	in	light	of	the	
numerous	and	subtle	caveats	and	confounds	associated	with	interpreting	these	data.
Data	access	requests	from	all	academic	or	commercial	researchers	(with	no	exclusive	or	preferential	access)	are	
processed	by	the	UK	Biobank’s	Research	Access	Administration	Team	and	approved	relatively	rapidly	provided	
that	they	fulfill	UK	Biobank’s	aims	of	supporting	health	research	in	the	public	interest.	Researchers’	institutions	
then	sign	a	Material	Transfer	Agreement	agreeing	not	to	attempt	to	identify	any	participant,	and	to	return	any	
derived	data	(e.g.,	new	IDPs)	to	UK	Biobank,	to	be	made	available	to	other	approved	researchers	after	an	agreed	
“embargo”	period	(to	allow	findings	to	be	published	or	IP	protected	by	the	researchers).	Thus,	while	the	first	set	
of	IDPs	described	here	from	internally	commissioned	research	is	being	made	available	immediately,	the	range	of	
IDPs	is	expected	to	grow	rapidly	as	additional	contributions	from	the	wider	user	community	are	added.
Protocol	Considerations
Design	of	the	brain	imaging	protocol	was	conducted	through	broad	consultation	with	neuroimaging	experts	and	
required	careful	balance	of	a	range	of	considerations,	often	specifically	relating	to	the	high	throughput	nature	of	
UK	Biobank.	In	setting	up	the	pilot	protocol,	the	primary	challenge	was	to	achieve	the	target	of	one	participant	
scanned	 every	 36	minutes	without	 serious	 compromise	 to	 data	 quality	 compared	 to	 research	 protocols	 that	
might	 conventionally	 require	 up	 to	 an	 hour	 of	 scan	 time.	 Despite	 these	 tight	 time	 constraints,	 we	 aimed	 to	
include	as	many	MRI	modalities	as	possible,	 to	 take	advantage	of	 the	 full	richness	of	 information	 that	 can	be	
provided	by	MRI.	Here,	we	highlight	the	primary	considerations	that	required	a	different	approach	from	more	
conventional	imaging	studies.
With	 each	 additional	minute	 of	 scanning	per	 subject	 effectively	 costing	 an	 additional	 ~£1million,	 there	 is	
enormous	value	associated	with	seemingly	small	efficiency	savings.	We	recovered	several	minutes	 of	 scan	
time	by	systematically	minimizing	the	overheads	associated	with	subject	placement,	scan	prescription,	and	
calibration	measurements.	For	example,	corrections	to	the	static	magnetic	field	homogeneity	(shimming) and	
strict	enforcement	of	a	single	shim	calibration	harvested	2	minutes	(changing	system	defaults	to	improve	and	
accelerate	shimming),	which	is	equivalent	to	the	scan	time	associated	with	some	of	the	included	modalities.
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Tight	 imaging	 FOVs	 (fields	 of	 view	 –	 the	 physical	 size	 of	 the	 imaged	 volume)	 are	 in	 general	 favorable	 to
reduce	scan	time;	however,	these	restrictions	exclude	subjects	with	larger	heads	or	brains.	For	UK	Biobank,	
even	a	 “conservative”	FOV	 that	 includes	99%	of	 the	population	will	 exclude	1000	participants.	As	detailed	
statistics	on	brain	size	(as	distinct	from	head	size)	were	not	available	in	the	literature,	we	conducted	a	study	
of	population	brain	size
54
	that	(in	conjunction	with	optimal	slice	angling)	enables	our	FOVs	to	target	99.9%.
It	 is	 critically	 important	 that	 all	 analyses	 are	 automated.	 This	 translates	 to	 an	 additional	 role	 for	 certain	
imaging	modalities	beyond	 their	 intrinsic	 information	 content.	 Thus,	 although	we	 considered	methods	 for	
reducing	scan	time for	T1-weighted	structural	scans	while	retaining	coverage	and	resolution	(e.g.,	elliptical	
sampling with	consequent	image	blurring),	this	was	deemed	an	unacceptable	risk	given	the	central	role	of	the	
T1	 to	 cross-subject	 and	 cross-modal	 alignment	 for	most	 processing	pipelines,	 including	 that	 implemented	
here	for	the	initial	data	release.
The	 EPI	 (echo-planar	 imaging)	 acquisitions	 for	 fMRI	 and	 dMRI	 result	 in	 significant	 image	 distortion	 that	
creates	local	misalignment	in	certain	brain	regions.	Correction	of	this	requires	measurement	of	the	magnetic	
field	 inhomogeneities	 that	 cause	 distortion.	 Two	 types	 of	 measurements	 are	 possible:	 a	 non-EPI	gradient-
echo	 acquisition	 with	 two	 echoes	 (conventional	 fieldmap)	 or	 two	 EPI-based	 spin	 echo	 acquisitions	 with	
opposite	phase	encode	direction
55
.	We	chose	the	latter,	which	can	be	incorporated	into	the	dMRI	protocol	as	
additional	b=0	scans	to	reduce	acquisition	time	(total	acquisition	time	~30s).
To	provide	data	with	as	rich	and	broad	a	 range	of	applications	as	possible,	we	 include	 imaging	modalities	
that	are	not	yet	widely	used	in	clinical	practice,	such	as	fMRI	and	dMRI.	These	modalities	have	demonstrated	
mechanistic	 and	 biological	 insights,	 and	 will	 hopefully	 see	 greater	 clinical	 take-up	 in	 the	 future,	 in	 part	
because	 of	 projects	 such	 as	 UK	 Biobank.	 We	 took	 advantage	 of	 recent	 advances	 in	 acquisition,	 largely	
developed	 as	 part	 of	 the	 Human	 Connectome	 Project, to	 obtain	 research	 quality	 data	 in	 limited	 time.
Specifically,	simultaneous	multi-slice	(or	multiband,	MB)	acquisitions
56-59
that	enable rapid	 fMRI	and	dMRI
without	sacrificing	statistical	robustness	or	directions/b-values
60
,	respectively.	Without	these	accelerations,	
a	seven-minute	dMRI	scan	of	the	same	spatial	resolution	would	have	been	 limited	 to	~32	directions	and	a	
single	shell,	precluding	NODDI
16
	and	other	more	advanced	biological	modeling.
After early piloting, a clinical T2/PD-weighted acquisition was removed from the protocol. This decision
reflected the limited relevance to UK Biobank goals (given the inclusion of the higher-quality and more 
biologically informative T2 FLAIR) and the value in recovering this scan time (just over 1 minute).
One	 shortcoming	 of	 the	 current	 protocol	 is	 the	 lack	 of	 a	 direct	measure	 of	 neurovascular	 health.	 We	 are	
piloting	a	 protocol	 change	 to	 include	 a	 2-minute	 perfusion	 scan	 (using	 arterial	 spin	 labeling).	 This	would	
require	reducing	task	fMRI	to	2	minutes;	while	this	is	an	extremely	short	task,	early	analyses	(using	truncated	
copies	of	existing	initial	tfMRI	datasets)	predict	that	it	will	be	sufficiently	robust.
A	major	ethical	question	in	studies	of	this	nature	relates	to	identification	and	handling	of	incidental	findings	
of	previously	unknown	pathology.	The	procedure	to	be	followed	in	UK	Biobank	has	been	considered	in	great	
depth	with	major	external	ethical,	legal	and	clinical	radiology	bodies,	and	with	the	funders	and	their	external	
review	 group.	 An	 assessment	 of	 different	 approaches	 to	 the	 identification	 of	 incidental	 findings	 and	 the	
impact	of	their	feedback	on	participants	and	the	health	service	has	been	conducted	as	part	of	the	pilot	phase	
of	UK	Biobank’s	imaging	project,	and	will	be	published	separately.		Based	on	its	results	and	the	deliberative	
process	undertaken	with	external	experts,	the	UK	Biobank	protocol	for	dealing	with	incidental	findings	does	
not	involve	the	routine	review	of	all	scans	for	potential	pathology	by	radiologists.	Instead,	if	a	radiographer	
incidentally	identifies	evidence	of	potentially	serious	pathology	(i.e.,	likely	to	threaten	life	span,	quality	of	life	
or	major	body	functions)	during	the	imaging	process	then	a	formal	radiologist	review	is	undertaken	and,	if	it	
is	confirmed	as	potentially	serious,	feedback	is	given	to	the	participant	and	their	doctor.
Informed	 consent	 is	 obtained	 from	 all	 UK	 Biobank	 participants;	 ethical	 procedures	 are	 controlled	 by	 a	
dedicated	Ethics	 and	Guidance	Council	 (http://www.ukbiobank.ac.uk/ethics)	 that	 has	 developed	with	 UK	
Biobank	 an	 Ethics	 and	 Governance	 Framework	 (given	 in	 full	 at	http://www.ukbiobank.ac.uk/wp-
content/uploads/2011/05/EGF20082.pdf),	 with	 IRB	 approval	 also	 obtained	 from	 the	 North	 West	Multi-
centre	Research	Ethics	Committee.
Subjects	 are	 excluded	 from	 scanning	 according	 to	 fairly	 standard	 MRI	 safety/quality	 criteria,	 such	 as	
exclusions	 for	metal	 implants,	 recent	 surgery,	 or	 health	 conditions	 directly	 problematic	 for	MRI	 scanning,	
such	as	problems	hearing,	breathing	or	extreme	claustrophobia.
Once	 the	 second	 and	 third	 imaging	 centers	 are	 complete	 and	 running,	 UK	 Biobank will	 use	 non-human	
phantom	objects	and	traveling	volunteers	to	confirm	quality	and	consistency	across	sites.
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Structural	Imaging
The	 T1	 structural	 protocol	 is	 acquired	 at	 1mm	 isotropic	 resolution	 using	 a	 3D	 MPRAGE	 acquisition,	 with	
inversion	 and	 repetition	 times	 optimized	 for	 maximal	 contrast.	 The	 superior-inferior	 field-of-view	 is	 large	
(256mm),	at	little	cost,	in	order	to	include	reasonable	amounts	of	neck/mouth,	as	those	areas	will	be	of	interest	
to	some	researchers	(for	example,	in	the	study	of	sleep	apnea).	Pre-processing	of	this	modality	included	removal	
of	the	face	(which	was	deemed	important	to	subject	anonymisation	for	the	standard	data	dissemination),	brain	
extraction	 (removal	 of	 non-brain	 tissues	 from	 the	 image),	 linear	 alignment	 to	 the	 standard	 MNI152	 brain	
template
61
	and	non-linear	warping	to	this	template
62
	to	maximize	correspondence	across	individuals	in	light	of	
significant	cross-subject	variation	in	brain	structure.	These	alignments	are	used	throughout	the	majority	of	the	
processing	pipeline	for	other	modalities.
T1	images	are	further	analyzed	to	estimate	volumes	of	a	range	of	tissues	and	structures	in	each	subject,	which	
may	reflect	atrophy	due	to	age	and	disease,	as	well	as	normal	variation	due	 to	 (e.g.)	use-dependent	plasticity.	
Images	are	 segmented	 into	 tissue	 types	 (gray	matter,	white	matter	 and	 cerebro-spinal	 fluid)
63
.	 	 Cortical	 gray	
matter	 volume	 is	 estimated,	 comparing	 the	 segmented	 gray	matter	 to	 an	atlas	 reference	 (where	 the	 external	
skull	 surface	 is	used	 to	 normalize	 for	 head	 size)
64
.	 	 Sub-cortical	 volumes	 are	 estimated
65
,	utilizing	 population	
priors	on	shape	and	intensity	variation	across	subjects.	T1-based	IDPs	are	generated	for	the	volumes	of	major	
tissue	types	of	the	whole	brain	and	for	specific	structures	(primarily	sub-cortically).
Too	much	reliance	on	spatial	registration	could	limit	the	usefulness	or	accuracy	of	some	IDPs.	This	is	in	part	why	
many	 of	 the	 IDPs	 are	 in	 fact	 generated	 from	within-subject	 analyses	 that	 do	 not	 depend	on	 exact	 voxelwise
spatial	alignment	to	standard	space	(or	between	subjects):	for	example,	283	of	the	715	structural	and	diffusion	
IDPs	do	not	rely	on	exact	spatial	alignment	and	are	carried	out	in	the	original	space	of	each	subjects’	data.
The	 T2	 protocol	 uses	 a	 fluid-attenuated	 inversion	 recovery	 (FLAIR)	 contrast	 with	 the	 3D	 SPACE	 optimized	
readout
66
.	This	shows	strong	contrast	for	white	matter	hyperintensities.	An	automated	pipeline	for	delineating	
these	 hyperintensities	 is	 currently	 being	 developed	 and	 future	 data	 releases	 will	 include	 IDPs	 reflecting	 the	
lesion	“load”.
The	 swMRI	 scan	 uses	 a	 3D	 gradient	 echo	 acquisition	 at	 0.8x0.8x3mm	 resolution,	 acquiring	 two	 echo	 times	
(TE=9.4	 and	 20	 ms).	 Anisotropic	 voxels	 can	 enhance	 certain	 contrast	 mechanisms,	 particularly	 for	 vascular	
conspicuity	due	to	through-plane	dephasing	effects,	but	are	less	ideal	for	other	susceptibility-based	processing.	
Ultimately,	however,	this	choice	was	motivated	by	the	desire	for	whole	brain	coverage	in	the	face	of	very	limited	
scan	time	(2.5	minutes).	Signal	decay	times	(T2*)	are	estimated	from	the	magnitude	images	at	the	two	TEs,	and	
the	generated	IDPs	are	the	median	T2*	estimated	within	the	various	subcortical	regions	delineated	from	the	T1	
processing.	Venograms are generated through non-linear filtering of the magnitude and phase images12, 
which produces enhanced conspicuity of medium and large veins. Automated segmentation of microbleeds
and venograms would provide significant value, but to our knowledge robust tools for this are not yet 
available; future pipeline versions can hope to include such analyses. Future work will also consider whether 
this data will support quantitative susceptibility mapping, which would provide further information on tissue 
constituents as discussed in the main text. 
Diffusion	Imaging
Diffusion	 data	 is	 acquired	 with	 two	 b-values	 (b=1000	 and	 2000	 s/mm
2
)	 at	 2mm	 spatial	 resolution,	 with	
multiband	 acceleration	 factor	 of	 3	 (three	 slices	 are	 acquired	 simultaneously	 instead	 of	 just	 one).	 For	 each
diffusion-weighted	 shell,	 50	 distinct	 diffusion-encoding	 directions	 were	 acquired	 (covering	 100	 distinct	
directions	over	the	two	b-values).	The	diffusion	preparation	is	a	standard	(“monopolar”)	Stejskal-Tanner	pulse	
sequence.	This	enables	 higher	 SNR	due	 to	 a	 shorter echo	 time	 (TE=92ms)	 than	 a	 twice-refocused	 (“bipolar”)	
sequence	at	the	expense	of	stronger eddy	current	distortions,	which	are	removed	using	the	Eddy	tool
67
	(which	
also	corrects	for	static	field	distortion	and	motion
68
).
Both	diffusion	tensor	and	NODDI	models	are	fit	voxel-wise,	and	IDPs	of	the	various	model	outputs	are	extracted	
from	a	set	of	white	matter	tracts.	Tensor	fits	utilize	the	b=1000 s/mm
2
	data,	producing	maps	including	fractional	
anisotropy,	 tensor	 mode	 and	 mean	 diffusivity.	 The	 NODDI
16
	 model	 is	 fit	 using	 the	 AMICO	 (Accelerated 
Microstructure Imaging via Convex Optimization)	tool
52
,	with	outputs	including	intra-cellular	volume	fraction	
(which	 is	 often	 interpreted	 to	 reflect	 neurite	 density)	 and	 orientation	 dispersion	 (a	measure	 of	 within-voxel	
disorganization).	 For	 tractography,	 a	 parametric	 approach	 is	 first	 used	 to	 estimate	 fibre	 orientations.	 The	
generalised	ball	&	stick	model	 is	 fit	 to	 the	multi-shell	 data,	 estimating	 up	 to	 3	 crossing	 fibre	 orientations	 per	
voxel.
17,	 69
Tractography	is	then	performed	in	a	probabilistic	manner	to	estimate	white	matter	pathways	using	
the	voxel-wise	orientations.
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Cross-subject	 alignment	 of	 white	 matter	 pathways	 is	 critical	 for	 extracting	 meaningful	 IDPs;	 here,	 two	
complementary	approaches	are	used.	The	first	used	tract-based	spatial	statistics	(TBSS
18,	70
),	in	which	a	standard-
space	white	matter	 skeleton	 is	mapped	 to	 each	 subject	 using	 a	 high-dimensional	warp,	 after	which	ROIs	 are	
defined	as	the	intersection	of	the	skeleton	with	standard-space	masks	for	48	tracts
71
	(see	the	“JHU	ICBM-DTI-81	
white-matter	 labels	atlas”	described	at	fsl.fmrib.ox.ac.uk/fsl/fslwiki/Atlases	for	definitions	of	the	tract	regions	
and	 names).	 The	 second	 approach	 utilizes	 subject-specific	 probabilistic	 diffusion	 tractography	 run	 using	
standard-space	 protocols	 to	 identify identify	 27	 tracts
18
;	 in	 this	 case,	 the	 output	 IDPs	 are	 weighted	 by	 the	
tractography	 output	 to	 emphasize	 values	 in	 regions	 that	 can	 most	 confidently	 be	 attributed	 to	 the	 tract	 of	
interest.	Currently,	no	structural	 connectivity	estimates	 from	the	diffusion	 tractography	are	provided	as	 IDPs,	
but	the	probabilistic	maps	are	available	and	future	work	will	generate	measures	similar	to	those	provided	for	
resting-state	fMRI.
Functional MRI
Task	and	resting-state	fMRI	use	the	same	acquisition	parameters,	with	2.4mm	spatial	resolution	and	TR=0.735s,	
with	multiband	 acceleration	 factor	 of	 8.	 A	 “single-band”	 reference	 image	 (without	 the	 multiband	 excitation,	
exciting	each	 slice	 independently)	 is	 acquired	 that	 has	 higher	 tissue-type	 image	 contrast;	 this	 is	 used	 as	 the	
target	 for	motion	 correction	 and	 alignment.	 For	 both	 data	 sets,	 the	 raw	 data	 are	 corrected	 for	motion
72
	 and	
distortion
55
	and	high-pass	filtered	to	remove	temporal	drift.	
The	task	scan	used	the	Hariri	 faces/shapes	“emotion”	task
21,	 73
,	as	 implemented	in	the	HCP
22,
,	but	with shorter	
overall	duration	and	hence	fewer	total	stimulus	block	repeats.	The	participants	are	presented	with	blocks	of	face	
or	shape	trials	and asked	to	decide	which	of	two	faces	(or	shapes)	presented	on	the	bottom	of	the	screen	match	
the	 face	 (or	 shape)	 at	 the	 top	 of	 the	 screen.	 The	 faces	 have	 either	 angry	 or fearful	 expressions.	 The	 ePrime
stimulus	 script	 is	 available	 for	 download (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=1462). Task-
induced	activation	is	modeled	with	FEAT,	including	auto-correlation	correction
74
,	using	5	activation	contrasts.	Of	
these,	 the	 three	 activation	 contrasts	 of	 most	 interest	 (shapes,	 faces	 and	 faces>shapes)	 are	 used	 to	 generate	
output	measures,	including	two	IDPs	for	the	faces-shapes	task	(one	including	all	voxels	above	a	group-level	fixed-
effects	 Z>120,	 and	 one	 including	 only	 the	 amygdala	 regions	 above	 threshold).	 IDPs	 corresponding	 to	 both	
percent	signal	change	and	statistical	significance	(Z	statistics)	are	generated.
During	resting-state	scans,	subjects	are	instructed	to	keep	their	eyes	fixated	on	a	crosshair,	relax	and	“think	of	
nothing	 in	 particular”.	 Resting-state	 are	 identified	 using	 ICA	 (independent	 component	 analysis
33,	 75
),	 which	
identifies	components	within	the	data	that	are	spatially	 independent	(where	a	component	comprises	a	 spatial	
map	and	a	single	associated	time	course).	Following	the	pre-processing	described	above,	resting-state	fMRI	data	
for	each	subject	 is	 further	“cleaned”	using	an	 ICA-based	algorithm	 for	automatically	 identifying	and	removing	
structured	 artefacts
76
.	 This	 data	 is	 fed	 into	 group-level	 ICA	 (including	 an	 initial	 group-level	 dimensionality	
reduction
77
),	which	is	used	to	parcellate	the	data	set	into	sets	of	25	and	(separately)	100	spatially-independent	
components.	 Where	 a	 small	 (<30)	 number	 of	 components	 is	 estimated
78
,	 it	 is	 common	 to	 consider	 each	
component	as	a	separate	“network”	in	its	own	right; each	component	will	often	include	several	non-contiguous	
regions,	 all	 having	 the	 same	 timecourse	 (according	 to	 the	 model).	 If	 a	 higher	 number	 of	 components	 is	
estimated
79
,	these	are	more	likely	to	be	smaller	regions	(parcels),	which	can	then	be	considered	as	nodes	for	use	
in	network	analysis
80
,	where	the	spatial	maps	are	used	to	define	subject-specific	time	courses	(the	first	stage	of	
dual	regression
1
).	These	time	courses	are	used	to	estimate	the	size	of	signal	fluctuation	in	each	node,	as	well	as	to	
estimate	 connectivity	 between	 pairs	 of	 nodes	 using	 L2-regularised	 partial	 correlation
81
.	 The	 connectivity	
estimates	are	provided	as	IDPs	at	both	parcellation	dimensionalities	(25	and	100	nodes);	after	removal	of	group-
ICA	 components	 considered	 to	 be	 artefactual	 (i.e.,	 relating	 either	 to	 scanning	 artefacts,	 or	 to	 non-neuronal	
biophysical	processes	 such	 as	 cardiac	 fluctuations	 and	head	motion),	 this	 results	 in	 21	 and	 (respectively)	55	
nodes	left	for	forming	the	IDPs	such	as	network	matrices	(functional	connectivities	between	pairs	of	nodes).
Quality	control
To	 date,	 raw	 data	 and	 pipeline	 outputs	 have	 been	 manually	 checked	 for	 gross	 problems	 of	 quality	 and	
robustness,	 with	 problematic	 data	 tagged	 and	 removed	 from	 pipeline	 outputs;	 see	 main	 text	 for	 results	 on	
proportions	of	usable	data	 in	 the	different	modalities.	However	several	quality-related	 IDPs	are	automatically	
generated	 by	 the	 pipeline	 (for	 example,	 number	 of	 outlier	 slices	 in	 the	 dMRI	 data,	 and	measures	 of	signal-to-
noise	ratio	in	the	various	modalities),	and	these	can	be	used	to	help	automatically	identify	problematic	data.	An	
expanded	set	of	such	quality	measures	is	being	produced,	in	addition	to	an	automated	machine	learning	system	
for	flagging	problematic	data	on	the	basis	of	the	many	IDPs	and	quality	measures;	future	versions	of	the	pipeline	
and	data	releases	will	benefit	from	the	results	of	these	ongoing	developments.
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Statistics
The	two	sections	below	describe	the	statistical	analysis	carried	out	using	IDPs	and	non-brain-imaging	measures.	
As	 described	 below,	 univariate	 statistics	 were	 primarily	 carried	 out	 using	 Pearson	 correlation	 (though	 see	
details	 below	 regarding	 Gaussian-distribution	 normalization	 and	 linear	 removal	 of	 confound	 effects)	 and	
multivariate	statistics	were	carried	out	using	a	combination	of	canonical	correlation	analysis	and	independent	
component	analysis	(with	permutation	testing	used	to	identify	the	significant	number	of	components	estimable).	
As	discussed	 in	 the	main	 text,	 the	primary	rationale	 for	 the	size	of	 the	study	 is	not	 to	 boost	 statistical	 power	
across	100,000	subjects,	but	rather	to	provide	prospective	imaging	data	suitable	for	discovering	early	markers	
and	 risk	 factors	 for	 as	 broad	 a	 set	 of	 diseases	 as	 possible,	 both	 rare	 and	 highly	 prevalent.	 Hence	 while	
calculations	have	been	made	 to	estimate	the	expected	numbers	of	 subjects	developing	different	diseases	 over	
coming	years	(see	introductory	section	of	main	text),	no	statistical	methods	were	used	to	pre-determine	sample	
sizes	for	any	one	specific	disease,	given	that	individual	disease	sample	sizes	are	not	prospectively	controlled,	and	
given	the	very	broad	expected	set	of	future	tests	between	different	imaging	measures	and	different	diseases	that	
will	be	ultimately	applied	from	this	prospective	long-term	resource.	Details	on	significance	testing	and	multiple	
comparison	corrections	are	included	in	the	two	sections	below.	A	Supplementary	Methods	Checklist	is	available.
Simple	associations	between	brain	IDPs	and	other	measures	
We	report	simple	correlation	analyses	between	each	of	the	2501	brain	 IDPs	and	each	of	1100	other	variables	
extracted	 from	the	UK	Biobank	database	 (these	 other	 variables	 are	mostly	 not	 derived	 from	 imaging,	 though	
some	do	come	from	the	non-brain	imaging	modalities);	for	the	list	of	general	classes	of	these	variables,	see	Fig.
6a,	and	for	many	examples	of	individual	variables,	see	the	lists	associated	with	the	CCA-ICA	modes	presented	in
Fig.	 7	 and	 Supplementary	 Figs.	 The	 initial	 set	 of	 variables	 extracted	 from	 the	 UK	 Biobank	 database	 was	
automatically	 reduced	 to	 those	 (1100	 variables)	 containing	 sufficient	 numbers	 of	 valid	 (non-missing)	 data	
entries,	 using	 very	 similar	 selection	 rules	 to	 those	 applied	 in	 the	 recent	 CCA-based	 analysis	 of	 Human	
Connectome	Project	data
34
. Some	variables	are	defined	(in	 the	UK	Biobank	database)	 such	 that	 the numerical	
encoding	is	the	inverse	of	what	one	might	naturally	assume	-	for	example	in	the	variable	"Qualifications",	higher	
numbers	refer	to lower	levels	of	educational	qualifications.	 In	such	cases	we	have inverted	the	sign	of	the	ICA	
weightings	 printed	 in	 the	 figures,	 for ease	 of	 interpretation.	 Further,	 some	 variables	 are	 categorical,	 with no	
clear	quantitative	meaning	to	the	values	(e.g.,	“Transport	type	to	work”);	where	we	find	an	apparent	association,	
this	can be	considered	to	be	indicative	of	a	real	association	(one	might	think	of	the	analysis	therefore	as	an	over-
conservative poor	implementation	of	an	ANOVA),	but	interpretation	of	the	sign	of	the	association clearly	needs	
care.	The	analysis	used	data	from	the	first	5430	subjects	scanned	and	having	usable	imaging	data:	age	range	44-
78y	(IQR	56-68y);	53%	of	subjects	were	female.
Eight	 confound	variables	 are	 generated:	 age,	 age
2
,	 sex,	 age×sex,	 age
2
×sex,	average	 head	motion	during	 tfMRI,	
average	head	motion	during	rfMRI	and	head	size.	To	enforce	Gaussianity, all	confound	variables,	 IDPs	and	non-
IDP	 variables	 are	 first	 passed	 through	 a	 rank-based	 inverse	 Gaussian	 transformation;	 this	 improves	 the	
robustness	of	correlations	(for	example,	to	avoid	undue	influence	of	potential	outlier	values).	The	confounds	are	
then	regressed	out	of	all	IDPs	and	non-IDP	variables	to	reduce	the	risk	of	finding	non-meaningful	associations.
For	example,	head	motion	corrupts	imaging	data	in	complex	ways
26
,	and	also	correlates	with	some	diseases	and	
with	 aging	 (r=0.15	 in	 this	 data);	 hence,	 if	 not	 adjusted	 for,	 uninteresting	 associations	 would	 likely	 arise.	
However,	some	measures	may	have	both	biologically	interesting	associations	with	IDPs,	and	also	act	as	imaging	
confounds.	For	example,	abnormal	heart	rate	or	blood	pressure	could	alter	 the	 fMRI	signal	 through	disrupted	
cerebral	auto-regulation	(independent	of	any	changes	to	neural	activity)
40
,	but	cardiovascular	pathology	could	
also	 be	 related	 to	 neurological	 pathology.	 Similarly,	 overall	 brain	 size	 and	 gray	 matter	 thickness	 IDPs	 are	
sensitive	simple	markers	of	aging	and	disease;	however,	these	properties	can	also	affect	other	IDPs	by	changing	
the	mixture	of	tissue	types	in	an	imaging	voxel,	creating	an	apparent	age/disease	dependence	that	is	driven	by	
the	volume	of	tissue	rather	than	the	properties	of	a	given	tissue	type	(such	as	fMRI	activation	or	white	matter	
microstructural	properties). It	is	therefore	important	to	interpret	apparent	associations	carefully.
The	 full	 set	 of	 2.8 million	 (2501×1100) Pearson correlations	 is	 then	 estimated	 and	 corrected	 for	 multiple	
comparisons.	Bonferroni	correction,	which	is	likely	to	be	somewhat	conservative	in	such	situations,	due	to	non-
independence	across	variables	tested,	resulted	in	pcorrected<0.05	being	equivalent	to	requiring	puncorrected<1.8×10
-8
.	
An	alternative	popular	approach	for	multiple	comparison	correction	is	false	discovery	rate	(FDR);
82
	we	use	the	
more	conservative	FDR	option	(making	no	assumption	of	variable	dependencies
83
),	resulting	here	in	requiring	
puncorrected<3.8×10
-5
.	These	two	 threshold	 levels	are	shown	with	dotted	 lines	 in	all	Manhattan	 plots	 in	 the	main	
figures.
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Multivariate	associations	between	brain	IDPs	and	other	measures
In	the	example	multivariate	analyses	shown	in	Figs	7-8,	canonical	correlation	analysis	(CCA
32
)	combined	with	
independent	component	analysis	(ICA
33
)	is	used	to	identify	several	“modes”	of	population	covariation	which	link	
multiple	brain	IDPs	to	sets	of	other	Biobank	variables.	This	is	very	similar	to	the	methodology	used	recently	to	
identify	a	single	mode	of	population	covariation	between	imaging	measures	and	many	behavioral	and	lifestyle	
measures	in	data	from	461	subjects	in	the	Human	Connectome	Project
8,	34
.
IDP	and	non-IDP	variables	are	prepared	as	for	the	univariate	correlation	analyses	described	above,	resulting	in	a	
brain-IDP	matrix	of	size	5034×2501	(subjects	×	IDPs)	and	a	non-IDP	matrix	of	size	5034×1100	(subjects	×	non-
IDP	variables).	The	 intention	 is	 to	 feed	 these	 into	 CCA	 in	order	 to	 identify	 population	modes	 linking	multiple	
variables	from	both	matrices.	However,	in	order	to	avoid	an	over-determined	(rank	deficient)	CCA	solution,	we	
first	compress	both	matrices	along	the	respective	phenotype	dimension	to	200	columns	(i.e.,	much	smaller	than	
the	numbers	of	subjects).	This	was	done	by	separately	reducing	each	matrix	to	the	top	200	subject-eigenvectors	
using	PCA.	To	achieve	this	while	avoiding	the	problem	of	missing	data,	we	use	the	approach	detailed	recently
34
	of	
estimating	 first	 a	 pseudo-covariance	 matrix	 ignoring	 missing	 data,	 projecting	 this	 onto	 the	 nearest	 valid	
(positive	definite)	covariance	matrix,	and	then	carry	out	an	eigenvalue	decomposition.	The	 two	resulting	 (IDP	
and	non-IDP)	matrices	of	size	5034×200	are	then	fed	into	standard	CCA	(“canoncorr”	in	Matlab),	resulting	in	200	
CCA	 modes	 being	 estimated.	 The	 CCA	 aims	 to	 identify	 symmetric	 linear	 relations	 between	 the	 two	 sets	 of	
variables.	Each	significant	CCA	mode	 identifies	a	 linear	 combination	 of	 IDPs	 and	 a	 linear	combination	 of	non-
IDPs,	where	 the	variation	 in	mode	strength	across	subjects	 is	maximally	 correlated.	That	 is,	CCA	 finds	modes	
that	relate	sets	of	brain	measures	to	sets	of	subjects’	non-brain-imaging	measures;	for	a	graphical	illustration	of	
this	approach,	see	Smith	et	al
34
	(Supplementary	information).
Permutation	testing	is	then	applied	to	estimate	(family-wise-error,	multiple-comparison-corrected)	p-values	for	
the	CCA	modes	estimated.	Nine	modes	are	 found	 to	be	significant	 (Pcorrected<0.002,	with	all	 later	modes	having	
Pcorrected>0.05).	 Because	 CCA	 can	 in	 general	 only	 unambiguously	 estimate	 distinct	modes	 up	 to	 an	 orthogonal	
rotation	amongst	them	(by	direct	analogy	to	PCA),	we	identify	a	non-ambiguous	unmixing	of	the	modes	using	
ICA	to	optimize	the	 final	set	of	modes	reported.	Because	we	expect	meaningful	population	modes	 to	be	much	
more	structured	(for	example,	sparser)	in	the	cross-variable	dimension	than	in	the	cross-subject	dimension,	we	
calculate	ICA	components	that	are	statistically	independent	from	each	other	in	the	cross-variable	dimension.	In	
order	 to	 take	 full	 advantage	 of	 the	 numbers	 of	 variables	 originally	 prepared,	 we	 first	multiply	 the	 nine	 CCA	
subject-weight	 vectors	 into	 the	 original	 IDP	 and	 non-IDP	 data	 matrices	 (after	 concatenating	 these	 across	
variables),	resulting	in	nine	CCA	variable-weight	vectors	of	length	2501+1100=3601.	These	nine	vectors	are	then	
fed	into	FastICA
33
	 in	order	 to	estimate	nine	population	data	sources	having	maximal	 statistical	 independence.	
This	general	approach	(CCA,	followed	by	concatenation	of	CCA	weight	vectors,	followed	by	ICA)	is	similar	to	that	
proposed	by	Sui
84
,	except that	we	return	to	the	full	feature	space	(as	described	above)	for	the	ICA	stage,	rather	
than	 staying	 in	 the	 PCA-reduced	 space.	 The	 ICA	 result	 is	 extremely	 robust,	 with	 split-half	 (cross-subjects)	
reproducibility	across	the	9	ICA	components	of	r>0.89.	Interestingly,	5	of	these	ICA	modes	(including	modes	7,	8	
and	9,	shown	in	Fig.	7)	are	virtually	unchanged	if	the	de-confounding	step	was	omitted	(correlation	of	variable-
weights	vectors:	r>0.8).
Data,	code	and	results	availability
As	described	 above,	 all	 source	 data	 (including	 raw	 and	processed	brain	 imaging	 data,	 derived	 IDPs,	 and	non-
imaging	 measures)	 is	 available	 from	 UK	 Biobank	 via	 their	 standard	 data	 access	 procedure	 (see	
www.ukbiobank.ac.uk/register-apply).	
The	 image	 processing	 pipeline	 will	 be	 made	 publicly	 available	 in	 early	 2017	 from	
www.fmrib.ox.ac.uk/ukbiobank	-	this	 is	the	pipeline	used	to	process	 the	raw	 imaging	data	and	generate	IDPs,	
and	hence	is	not	needed	in	order	to	replicate	the	results	of	this	paper,	which	could	be	achieved	by	accessing	IDPs	
as	described	above,	and	then	using	the	IDP	analysis	code	described	below.	
The	Matlab	code	for	the	univariate	and	multivariate	tests	described	in	this	paper,	and	the	results	of	those	tests	
(all	univariate	correlations	and	multivariate	weight	vectors)	are	available	from	www.fmrib.ox.ac.uk/ukbiobank	-
this	online	resource	will	be	updated	as	more	subjects’	data	and	more	IDPs	become	available.
Higher	resolution	supplementary	figures	are	available	as	a	supplementary	note.
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	r					r-raw		Pcorr		Pcorr-raw		Brain	IDP																																									Cognitive	test	score	
-0.10		-0.21		3.7e-02		3.8e-25		dMRI	TBSS	MD	Superior	corona	radiata	R												Number	of	symbol	digit	matches	attempted	
-0.11		-0.22		9.9e-03		7.8e-29		dMRI	TBSS	L1	Posterior	corona	radiata	R											Number	of	symbol	digit	matches	attempted	
-0.10		-0.20		2.7e-02		1.7e-21		dMRI	TBSS	L1	Posterior	corona	radiata	L											Number	of	symbol	digit	matches	attempted	
-0.10		-0.21		4.3e-02		3.4e-26		dMRI	ProbtrackX	MD	Superior	thalamic	radiation	L		Number	of	symbol	digit	matches	made	correctly	
-0.11		-0.22		1.2e-02		2.7e-28		dMRI	ProbtrackX	MD	Superior	thalamic	radiation	L		Number	of	symbol	digit	matches	attempted	
-0.11		-0.21		1.8e-02		2.5e-25		dMRI	ProbtrackX	MD	Superior	thalamic	radiation	R		Number	of	symbol	digit	matches	attempted	
-0.11		-0.23		1.4e-03		1.8e-30		dMRI	ProbtrackX	L1	Superior	thalamic	radiation	L		Number	of	symbol	digit	matches	made	correctly	
-0.12		-0.23		4.0e-04		1.3e-32		dMRI	ProbtrackX	L1	Superior	thalamic	radiation	L		Number	of	symbol	digit	matches	attempted	
-0.11		-0.22		4.5e-03		1.7e-28		dMRI	ProbtrackX	L1	Superior	thalamic	radiation	R		Number	of	symbol	digit	matches	made	correctly	
-0.12		-0.23		4.6e-04		2.4e-31		dMRI	ProbtrackX	L1	Superior	thalamic	radiation	R		Number	of	symbol	digit	matches	attempted	
	0.11			0.26		1.9e-02		5.0e-41		dMRI	TBSS	FA	Fornix	crus	+	Stria	terminalis	R					Number	of	symbol	digit	matches	attempted	
	0.10			0.26		3.1e-02		2.7e-44		T1	FIRST	Right	thalamus	volume																				Number	of	symbol	digit	matches	attempted	
-0.08		-0.16		3.7e-02		7.4e-27		T1	FIRST	Left	putamen	volume																						Mean	time	to	correctly	identify	matches	
-0.13		-0.13		3.8e-02		4.1e-02		tfMRI	Median	Z-statistic	Shapes																			Fluid	intelligence	score	
-0.13		-0.13		5.4e-03		5.1e-03		tfMRI	90th-percentile	Z-statistic	Shapes										Fluid	intelligence	score
b
0    Density (a.u.)    1
		ICA	%	%raw											CCA-ICA	mode	8	
	-8.4	20	13	Diastolic	blood	pressure	
	-8.4	23	22	Mean	arterial	pressure	during	PWA	
	-8.2	16	14	Diastolic	brachial	blood	press	during	PWA	
	-7.8	19	21	End	systolic	pressure	during	PWA	
	-6.8	18	20	Central	systolic	blood	pressure	during	PWA	
	-6.6	19	21	Systolic	brachial	blood	press	during	PWA	
	-6.0	15	17	Systolic	blood	pressure	
		3.8		2		4	dMRI	TBSS	OD	Cingulum	hippocampus	R	
	-3.8		2		4	Red	Blood	Cell	Count	
		3.7		1		0	Handedness	
		3.6		2		3	dMRI	TBSS	OD	Cingulum	hippocampus	L	
	-3.6		1		1	dMRI	TBSS	FA	Sup	cerebellar	peduncle	R	
	-3.4		2		2	dMRI	TBSS	MO	Cingulum	hippocampus	R	
	-3.4		3		3	Alcohol	intake	frequency	
	-3.3		2		6	Haemoglobin	Concentration	
	-3.3		5	38	dMRI	TBSS	L1	Sup	longitudinal	fasciculus	L	
	-3.3		1		0	dMRI	TBSS	FA	Sup	cerebellar	peduncle	L	
		3.3		3		9	dMRI	TBSS	OD	Sup	longitudinal	fasciculus	L	
		3.3		1		3	dMRI	TBSS	OD	Sup	cerebellar	peduncle	R	
		3.2		3	19	dMRI	TBSS	OD	Posterior	corona	radiata	R	
	-3.2		2		2	Alcohol	consumed	
		3.2		2		9	dMRI	TBSS	OD	Sup	longitudinal	fasciculus	R	
	-3.0		2		5	dMRI	TBSS	MO	Sup	longitudinal	fasciculus	L	
		3.0		1		0	rfMRI	connectivity	(ICA100	edge	295)	
	-2.9		1		0	SWI	T2*	left	hippocampus	
		2.9		3	18	dMRI	TBSS	OD	Posterior	corona	radiata	L	
	-2.9		2		1	rfMRI	connectivity	(ICA100	edge	207)
		ICA	%	%raw											CCA-ICA	mode	7	
	15.9	20	18	T1	SIENAX	brain	normalised	volume	
	15.8	20		9	T1	SIENAX	brain	unnormalised	volume	
-15.2		3		1	Head	bone	mineral	content	
-14.9		3		0	Head	bone	mineral	density	
	14.0	18	13	T1	SIENAX	grey	unnormalised	volume	
	13.9	18	16	T1	SIENAX	grey	normalised	volume	
	12.1	10		9	T1	SIENAX	white	normalised	volume	
	11.9	10		5	T1	SIENAX	white	unnormalised	volume	
	11.3	14	12	T1	SIENAX	periph	grey	unnormalised	volume	
	11.3	14	15	T1	SIENAX	periph	grey	normalised	volume	
		9.4	10	58	dMRI	TBSS	FA	Genu	of	corpus	callosum	
		9.2		8	15	T1	FIRST	right	thalamus	volume	
		9.0		8	15	T1	FIRST	left	thalamus	volume	
		8.9		9	57	dMRI	TBSS	FA	Body	of	corpus	callosum	
		7.8		3		3	T1	FIRST	brain	stem+4th	ventricle	volume	
	-7.7		9	58	dMRI	TBSS	L3	Genu	of	corpus	callosum	
		7.5		8	13	Number	of	symbol	digit	matches	attempted	
	-7.5		8	53	dMRI	TBSS	L2	Genu	of	corpus	callosum	
		7.5		5		8	T1	FIRST	left	putamen	volume	
		7.3		5	49	dMRI	TBSS	FA	External	capsule	R	
	-7.2		8	57	dMRI	TBSS	L2	Body	of	corpus	callosum	
		7.1		7	12	Number	of	symbol	digit	matches	correct	
		7.1		9	23	dMRI	TBSS	MO	Body	of	corpus	callosum	
		7.0		5	45	dMRI	TBSS	FA	External	capsule	L	
		7.0		7	57	dMRI	TBSS	ICVF	Posterior	corona	radiata	L	
		6.9		3		8	T1	FIRST	right	putamen	volume	
	-6.8		7	55	dMRI	TBSS	L3	Body	of	corpus	callosum	
		6.8		4	46	dMRI	TBSS	FA	Posterior	corona	radiata	L	
		6.8		7	55	dMRI	TBSS	ICVF	Posterior	corona	radiata	R	
		6.8		5	55	dMRI	TBSS	ICVF	Genu	of	corpus	callosum	
		6.7		5	40	dMRI	TBSS	FA	Cingulum	cingulate	gyrus	L	
		6.7		6	67	dMRI	ProbtrackX	ICVF	Sup	long	fascic	L	
		6.7		6	39	dMRI	TBSS	FA	Fornix	crus+Stria	term	R	
		6.7		5	55	dMRI	ProbtrackX	FA	forceps	minor	
		6.6		6	61	dMRI	TBSS	ICVF	Sup	long	fascic	L	
		6.6		5	66	dMRI	ProbtrackX	ICVF	Inf	long	fascic	L	
	-6.5		7	53	dMRI	TBSS	L2	External	capsule	R	
		6.5		6	70	dMRI	TBSS	ICVF	Anterior	corona	radiata	R	
	-6.5		5		8	dMRI	TBSS	OD	Body	of	corpus	callosum	
	-6.5		5	55	dMRI	TBSS	L3	Splenium	of	corpus	callosum	
	-6.4		4	15	dMRI	ProbtrackX	L3	Parahipp	cingulum	r	
	-6.4		4		7	dMRI	TBSS	OD	Cingulum	cingulate	gyrus	L	
		6.4		6	68	dMRI	TBSS	ICVF	External	capsule	R	
		6.4		7		4	Forced	expiratory	volume	in	1-second	
		6.4		5	70	dMRI	ProbtrackX	ICVF	Inf	front-occ	fasc	L	
	-6.4		6	49	dMRI	TBSS	L2	External	capsule	L	
	-6.4		6	69	dMRI	ProbtrackX	L3	Inf	front-occ	fasc	L	
		6.4		5	57	dMRI	ProbtrackX	ICVF	Acustic	radiation	L	
		6.3		6	67	dMRI	TBSS	ICVF	External	capsule	L	
	-6.3		6	11	Duration	to	complete	alphanumeric	path	
	-6.2		6	49	dMRI	ProbtrackX	L3	Uncinate	fasciculus	r	
		6.2		4	20	dMRI	TBSS	FA	Sup	cerebellar	peduncle	L	
		6.2		5	47	dMRI	TBSS	ICVF	Splenium	corpus	callosum	
		6.2		5	38	dMRI	TBSS	FA	Ant	limb	of	int	capsule	L	
	-6.2		7	60	dMRI	TBSS	L3	Posterior	corona	radiata	L	
		6.2		2	24	dMRI	ProbtrackX	FA	Acoustic	radiation	L	
	-6.2		5	50	dMRI	TBSS	L3	External	capsule	L	
	-6.2		4	16	dMRI	ProbtrackX	L2	Parahipp	cingulum	R	
	-6.2		6	65	dMRI	ProbtrackX	L3	Inf	long	fascic	L	
	-6.1		6	52	dMRI	TBSS	L3	External	capsule	R	
	-6.1		7	66	dMRI	ProbtrackX	L3	Ant	thal	radiation	R	
		6.1		7	52	dMRI	TBSS	ICVF	Sup	front-occ	fasc	R	
		6.1		6	69	dMRI	TBSS	ICVF	Anterior	corona	radiata	L	
		6.0		4	44	dMRI	TBSS	ICVF	Uncinate	fasciculus	R	
		6.0		5	34	dMRI	TBSS	FA	Ant	limb	of	int	capsule	R	
		6.0		3	37	dMRI	TBSS	FA	Posterior	corona	radiata	R	
		6.0		5	65	dMRI	ProbtrackX	ICVF	Inf	long	fascic	R	
		6.0		5	34	dMRI	TBSS	FA	Fornix	crus+Stria	term	L	
	-6.0		6		8	Time	to	complete	round
		ICA	%	%raw											CCA-ICA	mode	9	
	12.7	17	15	Fluid	intelligence	score	
		9.3	12	10	Age	completed	full	time	education	
		8.8	10	10	Qualifications	
	-7.7		7		5	Time	spent	watching	television	
	-7.7		8		5	tfMRI	90th-percentile	zstat	shapes	
	-7.6		6		6	Job	involves	heavy	manual	or	physical	work	
	-7.5		6		5	Time	spend	outdoors	in	summer	
		7.5		8		5	Cheese	intake	
	-7.4		3		1	Head	bone	mineral	content	
	-7.3		5		8	Job	involves	mainly	walking	or	standing	
	-7.1		5	19	Duration	to	complete	alphanumeric	path	
	-6.9		6		7	tfMRI	median	BOLD	shapes	
	-6.9		6		7	tfMRI	90th-percentile	BOLD	shapes	
	-6.7		6		5	tfMRI	median	zstat	shapes	
	-6.6		5		3	Time	spent	outdoors	in	winter	
	-6.5		5		3	Frequency	of	travelling	from	home	to	job	
		6.3		4		2	rfMRI	connectivity	(ICA100	edge	177)	
	-5.8		2		0	Head	bone	mineral	density	
	-5.7		3	18	Duration	to	complete	numeric	path	
		5.6		4	13	Number	of	symbol	digit	matches	attempted	
		5.5		3		3	Childhood	sunburn	occasions	
		5.4		4	12	Number	of	symbol	digit	matches	correct	
	-5.3		3		1	Type	of	fat/oil	used	in	cooking	
		5.2		2		2	Spreads/sauces	consumers	
	-5.1		4		2	tfMRI	90th-percentile	zstat	faces	
		5.1		2		2	Time	spent	using	computer	
	-5.1		3		0	Time	spent	driving	
	-5.0		2		1	Maternal	smoking	around	birth	
		5.0		3		5	Maximum	digits	remembered	correctly	
		4.9		1	10	T1	SIENAX	CSF	unnormalised	volume	
	-4.9		3		3	rfMRI	amplitudes	(ICA100	node	6)	
		4.9		1		8	T1	SIENAX	CSF	normalised	volume	
	-4.8		3		3	tfMRI	median	zstat	faces	
	-4.7		3		4	tfMRI	median	BOLD	faces	
		4.7		3		1	Never	eat	eggs,	dairy,	wheat,	sugar	
		4.7		1		6	T1	SIENAX	brain-unnormalised	volume	
		4.6		3	11	dMRI	TBSS	ISOVF	Sup	cerebellar	peduncle	R	
	-4.5		1		0	SWI	T2*	left	hippocampus	
	-4.5		2		1	rfMRI	connectivity	(ICA100	edge	345)	
		4.4		1		1	Handedness	
		4.4		1		7	T1	SIENAX	white	unnormalised	volume	
		4.4		1		0	T1	SIENAX	white	normalised	volume	
		4.4		1		0	T1	SIENAX	brain-normalised	volume	
		4.4		4	13	dMRI	TBSS	L1	Sup	cerebellar	peduncle	L	
	-4.3		2		1	Exposure	to	tobacco	smoke	outside	home	
	-4.3		2		0	Ease	of	getting	up	in	morning	
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															ASPS														UK	Biobank	
									R2*-BMI	regression			T2*-BMI	regression	
													beta	-log10PFDR						beta	-log10Puncorr	
Thalamus						0.029		0								L	-0.0239			0.7	
																														R	-0.0187			0.5	
Caudate							0.046		0								L	-0.0789			4.5	
																														R	-0.0746			4.1	
Putamen							0.044		0								L	-0.0570			2.6	
																														R	-0.0649			3.2	
Pallidum					-0.002		0								L	-0.0661			3.2	
																														R	-0.0772			4.1	
Hippocampus			0.135		>4.0					L	-0.1390		14.2	
																														R	-0.1343		13.7	
																											MEAN	-0.1490		17.0	
Amygdala						0.232		2.0						L	-0.0786			4.6	
																														R	-0.0478			2.0	
																											MEAN	-0.0701			3.9	
Accumbens				-0.048		0								L	-0.0117			0.2	
																														R	-0.0040			0.1
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